Tag Archives: Sector Restrictions

Green and Low-Carbon Provisions in the Opinion on Developing New Quality Productive Forces

  • The green and low-carbon provisions sit in the third part of the Opinion, “focusing on innovating the development model”, which calls for building a green, low-carbon and circular economic system and for advancing the energy revolution.
    绿色低碳条款位于《意见》第三方面”着力推进发展方式创新”,提出构建绿色低碳循环发展经济体系,积极推进能源革命。
  • The text calls for building a power system with a high proportion of renewable energy and for improving policies on the consumption and regulation of new energy.
    文件提出构建高比例可再生能源电力系统,完善新能源消纳和调控政策措施。
  • “Orderly development of advanced nuclear fission energy” appears alongside renewables, but nuclear power remains a sector governed by the negative list; specific access is subject to the current negative list.
    “有序发展先进核裂变能”与可再生能源并列出现,但核电仍属《外商投资准入负面清单》管理领域,具体准入以现行负面清单为准。
  • The clause adds “all-round international co-operation”, framing the energy transition as an area open to cross-border participation.
    条款包含”全方位加强国际合作”,将能源转型定位为可跨境参与的领域。
  • According to public reports, the 2025 edition of the Catalogue of Industries for Encouraging Foreign Investment contains 1,679 entries, 205 more than the 2022 edition, and takes effect on 1 February 2026.
    据公开报道,《鼓励外商投资产业目录(2025 年版)》总条目 1679 条,比 2022 年版净增 205 条,自 2026 年 2 月 1 日施行。
  • Per public reports, the catalogue guides foreign investment towards advanced manufacturing, modern services and the central, western and north-eastern regions and Hainan, fields that include green equipment and environmental services.
    据公开报道,该目录引导外资投向先进制造业、现代服务业以及中西部地区、东北地区和海南省,其中涵盖绿色装备与环境服务等领域。
  • For foreign investors, the practical read is that green-sector opportunities are framed by encouraged-catalogue entries and sector restrictions together, not by the energy clause alone.
    对外资而言,实务判断应同时看鼓励目录条目与分行业准入限制,而非仅凭能源条款。

Green and Low-Carbon Provisions in the Opinion on Developing New Quality Productive Forces | 《关于发展新质生产力的意见》绿色低碳条款解读

Overview

The Opinion on Developing New Quality Productive Forces, issued in October 2026, sets out a framework for China’s economic development. This article looks only at one dimension of it: the green and low-carbon provisions, and what they mean in practice for foreign companies active in green industries. It does not cover the Opinion’s wider structure or its provisions on foreign venture capital and data flows, which are addressed separately.

The relevant text sits in the third part of the Opinion, “focusing on innovating the development model”. It is short but specific, and it is best read alongside the existing investment framework rather than in isolation.

What the green and low-carbon clauses say

The third part opens by setting a direction: “focusing on innovating the development model; build a green, low-carbon and circular economic system, improve the policy toolbox for green development, and actively advance the energy revolution.”

The energy paragraph then elaborates. Focused on the carbon-peaking and carbon-neutrality goals, the text calls for:

  • the orderly development of advanced nuclear fission energy;
  • building a power system with a high proportion of renewable energy;
  • improving policies for the consumption and regulation of new energy;
  • organising demonstration and roll-out of major application scenarios, and accelerating the greening of energy use across production and daily life;
  • advancing the revolution in energy consumption, supply, technology and systems, and strengthening international co-operation in all respects.

Two features stand out. First, the clause pairs generation-side language — renewable power and nuclear fission — with consumption-side language — new-energy consumption and regulation. Second, it closes with “all-round international co-operation”, which places the energy transition within a cross-border frame rather than a purely domestic one. That closing phrase is the main hook for foreign participation, and it is a statement of direction rather than a list of specific openings.

Sector boundaries: nuclear power and the negative list

The phrase “orderly development of advanced nuclear fission energy” should be read carefully. It appears in a paragraph about the energy mix, and it signals that advanced nuclear fission is part of the long-term energy picture. It does not, by itself, change the rules on who may invest in nuclear power.

Nuclear power remains a sector governed by the Catalogue of Industries for Foreign Investment and the Negative List for Foreign Investment Access. Foreign investment in nuclear power is restricted, and specific access is subject to the current negative list. A reader should therefore treat the energy paragraph as a technology-and-supply statement, not as a statement that nuclear operations are open to foreign investment. Where a project touches nuclear, the applicable rule is the negative list as it stands, not the energy clause.

The same discipline applies to the renewable-energy language. The Opinion states a direction — a power system with a high proportion of renewables, and improved consumption and regulation policies. It does not, in this text, set out capacity targets or consumption ratios. Investors should rely on the specific implementing documents that follow, not on inferred numbers.

The encouraged-investment catalogue as the practical frame

For a foreign company in green industries, the operative document is the Catalogue of Industries for Encouraging Foreign Investment. According to public reports, the 2025 edition contains 1,679 entries in total, a net increase of 205 over the 2022 edition, with 303 entries revised. Of these, the national catalogue has 619 entries (100 added, 131 revised) and the catalogue for central and western regions and other areas has 1,060 entries (105 added, 172 revised). The catalogue guides foreign investment towards advanced manufacturing, modern services and the central, western and north-eastern regions and Hainan. It takes effect on 1 February 2026, when the 2022 edition is repealed.

These figures are reported by the media and should be treated as publicly reported information rather than as text of the Opinion. Their significance for green industries is that encouraged-catalogue entries are the main mechanism through which green manufacturing, new-energy equipment and environmental services are signalled as welcome areas. A company should check whether its activity appears in the catalogue, and should read that against the sector restrictions in the negative list.

Practical implications for foreign green-industry investors

The following are practical observations, not official commitments:

  • Read the two lists together. The encouraged catalogue and the negative list work as a pair. An activity can be encouraged in general and still restricted in a specific sub-sector; the negative list governs the restriction.
  • Match the technology to the direction. The Opinion’s language points to renewable generation, new-energy consumption and regulation, and demonstration scenarios. A company whose technology fits one of these directions has a clearer policy reference point.
  • Treat nuclear separately. Given that nuclear power is governed by the negative list, a nuclear-related project should be assessed under that regime rather than under the energy paragraph.
  • Watch for implementing documents. The Opinion sets direction. Capacity targets, consumption rules and incentive details will come through separate implementing documents; those, not the Opinion alone, will carry the operational detail.
  • Use the regional dimension. The encouraged catalogue’s regional sections indicate that investment in the central, western and north-eastern regions and Hainan is a specific focus, which may be relevant to siting decisions.

Related considerations

The Opinion also frames the transition as one that runs across consumption, supply, technology and systems, and it links this to international co-operation. For a foreign investor, the practical consequence is that green-industry opportunities in China are defined by the interaction of a policy direction, the encouraged-investment catalogue and the sector restrictions in the negative list. None of these alone is decisive. The Opinion provides the direction; the lists provide the operational boundaries; and the implementing documents that follow will provide the specifics.

Sources

  • 中国政府网:《关于发展新质生产力的意见》全文:https://www.gov.cn/yaowen/liebiao/202610/content_7082824.htm
  • 中国网:新华社受权发布《关于发展新质生产力的意见》(含能源革命条款):https://big5.china.com.cn/gate/big5/news.china.com.cn/2026-10/10/content_118727382.shtml
  • 央视网:关于《关于发展新质生产力的意见》的报道:https://big5.cctv.com/gate/big5/news.cctv.cn/2026/10/09/ARTID24yrFP8npsds5YwTvhn261009.shtml

《关于发展新质生产力的意见》绿色低碳条款解读

概述

2026 年 10 月印发的《关于发展新质生产力的意见》,为中国的经济发展确立了框架。本文只聚焦其中一个维度:绿色低碳条款,以及它们对在华经营绿色产业的外资企业在实务上的含义。本文不涉及《意见》的整体结构,也不涉及其关于外资创业投资与数据流动的表述,这些内容另文处理。

相关条文位于《意见》第三方面”着力推进发展方式创新”。文字简短但指向明确,宜与现行投资制度框架对照阅读,而非孤立理解。

绿色低碳条款说了什么

第三方面开篇定下方向:”着力推进发展方式创新。构建绿色低碳循环发展经济体系,优化绿色发展政策工具箱,积极推进能源革命。”

能源段落随后展开。围绕碳达峰碳中和目标,文件提出:

  • 有序发展先进核裂变能;
  • 构建高比例可再生能源电力系统;
  • 完善新能源消纳和调控政策措施;
  • 组织重大应用场景示范和推广,加速全社会生产生活用能绿色化进程;
  • 推动能源消费、供给、技术、体制革命,全方位加强国际合作。

有两点较为突出。其一,该条将发电侧表述——可再生能源电力与核裂变能——与消费侧表述——新能源消纳与调控——并列。其二,它以”全方位加强国际合作”收尾,将能源转型置于跨境框架之内,而非纯粹的国内议题。这一收尾表述是外资参与的主要切入点,属于方向性表述,而非具体开放清单。

分行业边界:核电与负面清单

“有序发展先进核裂变能”一语需要审慎理解。它出现在关于能源结构的段落中,表明先进核裂变能属于长期能源图景的一部分。但它本身并不改变谁可以投资核电的规则。

核电仍属《外商投资准入负面清单》管理领域。外资进入核电受到限制,具体准入以现行负面清单为准。因此,读者应将能源段落视为技术与供给层面的表述,而非核电运营对外资开放的表述。凡涉及核电的项目,适用规则是现行负面清单,而非能源条款本身。

同样的纪律适用于可再生能源表述。《意见》表明的是方向——高比例可再生能源电力系统,以及完善的消纳与调控政策。就本文而言,它并未给出装机目标或消纳比例数字。投资者应依据后续具体实施文件,而非推断出的数字。

鼓励类目录作为实务框架

对绿色产业外资企业而言,起实际作用的是《鼓励外商投资产业目录》。据公开报道,2025 年版总条目 1679 条,比 2022 年版净增 205 条,修改 303 条。其中,全国目录 619 条(增加 100 条、修改 131 条),中西部等地区目录 1060 条(增加 105 条、修改 172 条)。该目录引导外资投向先进制造业、现代服务业以及中西部地区、东北地区和海南省,自 2026 年 2 月 1 日施行,2022 年版同时废止。

上述数据来自媒体报道,应视为公开报道信息,而非《意见》原文。其对绿色产业的意义在于:鼓励类目录条目,是绿色制造、新能源装备与环境服务被标示为欢迎领域的主要机制。企业应核查自身业务是否列入目录,并将其与负面清单中的分行业限制对照阅读。

外资绿色产业投资者的实务含义

以下为实务观察,不构成官方承诺:

  • 两份清单对照阅读。 鼓励类目录与负面清单是一组配套文件。某一业务可能总体受鼓励,却在具体子行业受限制;限制以负面清单为准。
  • 让技术与方向匹配。 《意见》的表述指向可再生能源发电、新能源消纳与调控,以及示范场景。技术与上述某一方向契合的企业,政策参照点更清晰。
  • 核电单独评估。 鉴于核电由负面清单管理,涉核项目应按该制度评估,而非按能源段落评估。
  • 关注实施文件。 《意见》确定方向。装机目标、消纳规则与激励细节将通过单独的实施文件落地;承载操作细节的是这些文件,而非《意见》本身。
  • 善用区域维度。 鼓励类目录的区域部分表明,投向中西部地区、东北地区和海南省是一项具体侧重,这可能与选址决策相关。

相关考虑

《意见》还将转型表述为贯穿消费、供给、技术与体制的过程,并将其与国际合作相联结。对境外投资者而言,实务上的结论是:中国的绿色产业机会,由政策方向、鼓励类目录与负面清单中的分行业限制三者互动界定。三者中的任何一项单独都不具决定性。《意见》提供方向,两份清单提供操作边界,后续实施文件将提供具体细节。

来源

  • 中国政府网:《关于发展新质生产力的意见》全文:https://www.gov.cn/yaowen/liebiao/202610/content_7082824.htm
  • 中国网:新华社受权发布《关于发展新质生产力的意见》(含能源革命条款):https://big5.china.com.cn/gate/big5/news.china.com.cn/2026-10/10/content_118727382.shtml
  • 央视网:关于《关于发展新质生产力的意见》的报道:https://big5.cctv.com/gate/big5/news.cctv.cn/2026/10/09/ARTID24yrFP8npsds5YwTvhn261009.shtml

Brain-computer interface medical devices: China’s innovative registration policy direction

  • At the 2026 International Biomedical Industry Innovation Beijing Forum in Yizhuang, an official from the NMPA Medical Device Registration Management Department said brain-computer interface (BCI) has been incorporated into China’s 15th Five-Year Plan and written into the Government Work Report, and is positioned as a future industry.
    在2026国际生物医药产业创新北京论坛(北京亦庄)”神经调控与脑机接口技术产业发展论坛”上,国家药监局医疗器械注册管理司相关负责人表示,脑机接口已被纳入我国”十五五”规划、写入政府工作报告,明确作为未来产业予以布局。
  • The regulator signalled that supporting innovative registration and management policies will be introduced to systematically support the development and translation of BCI medical devices.
    药监部门表示将配套创新注册管理政策,系统支持脑机接口医疗器械的研发与落地转化。
  • As of end-July 2026, China had more than 347,000 valid medical-device registrations and filings; in 2025 the NMPA approved 14,187 medical-device registrations, up 8 per cent year on year.
    截至2026年7月底,全国有效医疗器械注册备案产品超过34.7万件;2025年国家药监局共批准医疗器械注册14187项,同比增长8%。
  • The “Spring Rain Action” clinical-translation programme has collected more than 400 Class III medical-device products and placed 22 quality projects into an expedited pre-review green channel.
    医疗器械临床创新成果转化”春雨行动”已征集400多个三类医疗器械产品,已有22个优质项目纳入审评前置绿色通道。
  • On standards, three industry standards for BCI have been issued, ten national standards and three industry standards are under development, and one international-standard proposal has been submitted, covering EEG acquisition, signal transmission, motor-intention decoding and device reliability.
    在标准方面,脑机接口领域已累计发布3项行业标准,立项10项国家标准、3项行业标准,并提交1项国际标准立项提案,覆盖脑电采集、信号传输、运动意图解码与设备可靠性等核心技术环节。
  • The regulator describes its approach as “front-loading regulation and standards first”, including pre-application technical guidance for both invasive and non-invasive products and unified naming and classification rules.
    监管方式被概括为”监管前置、标准先行”,包括对多款侵入式、非侵入式产品开展前置技术指导,并统一产品命名与分类界定规则。
  • For foreign companies the practical relevance is analytical rather than a formal commitment: the policy direction points to clearer registration pathways, but no specific BCI approval timelines, acceptance numbers or product names have been published.
    对境外企业而言,其实际意义属分析性判断而非官方承诺:政策方向指向更清晰的注册路径,但截至目前并未公布具体的脑机接口审批时限、受理编号或产品名称。

Brain-computer interface medical devices: China’s innovative registration policy direction | 脑机接口医疗器械:中国创新注册管理政策方向

Overview

In October 2026, the 2026 International Biomedical Industry Innovation Beijing Forum was held in Yizhuang, Beijing. At the forum’s “Neuromodulation and Brain-Computer Interface Technology Industry Development Forum”, an official from the Medical Device Registration Management Department of the National Medical Products Administration (NMPA) set out the regulator’s current reading of brain-computer interface (BCI) medical devices and the registration policy direction attached to them.

According to the remarks, BCI has been incorporated into China’s 15th Five-Year Plan and written into the Government Work Report, and is expressly positioned as a future industry. On that basis, the regulator said it would put in place supporting innovative registration and management policies to systematically support the research, development and translation of BCI medical devices.

The remarks are a policy-direction statement rather than a new rule. They describe how the existing medical-device registration system is being oriented towards BCI, and they rest on a set of published industry figures that show how the registration base and the innovation-support toolkit have grown.

Key developments

The official’s remarks combined a positioning statement with concrete numbers on China’s medical-device registration landscape.

  • Registration base. As of end-July 2026, China had more than 347,000 valid medical-device registrations and filings, spanning Class III registration certificates, Class II registration certificates and Class I filings.
  • Annual approvals. In 2025, the NMPA approved 14,187 medical-device registrations, an increase of 8 per cent year on year.
  • Clinical translation programme. The “Spring Rain Action” for the translation of clinical innovations in medical devices had collected more than 400 Class III medical-device products, covering high-end tracks such as BCI, interventional surgical robots, AI diagnostic software and high-end interventional implants and biomaterials. 22 quality projects had been placed into an expedited pre-review green channel.

Read together, these figures describe a large and still-growing registration pipeline, and a deliberate effort to move selected high-end products through review faster than the ordinary queue.

Standards first: the pre-review and standards toolkit

Alongside the registration figures, the remarks described the regulator’s operating approach as “front-loading regulation and standards first”.

On standards, the BCI field has seen:

  • three industry standards issued;
  • ten national standards and three industry standards initiated (立项); and
  • one international-standard proposal submitted.

The published standards cover core technical links including EEG acquisition, signal transmission, motor-intention decoding and device reliability.

On regulation, the approach includes:

  • advance planning of regulatory-science research;
  • pre-application technical guidance for a number of both invasive and non-invasive products; and
  • unified rules for product naming and classification.

The “standards first” logic matters for a technology like BCI, where the boundary between a medical device, a consumer wearable and a research instrument can be genuinely unclear. Naming and classification rules, and the existence of standards for core components, are the practical preconditions for a device to move into a defined registration pathway.

Next steps in regulation

The official set out the next steps in general terms: continuing to deepen reform of the medical-device review and approval system and to increase support for high-end innovative devices. Specific measures mentioned included:

  • optimising the review mechanism for “globally new” products;
  • providing front-loaded services such as clinical-trial pre-review and technical consultation; and
  • thereby accelerating the market launch of landmark products.

These are direction statements. They indicate where the regulator intends to concentrate facilitation effort, not the terms on which any individual product will be reviewed.

Practical implications for foreign companies

The following points are analytical observations, not official commitments. They describe what the policy direction may mean for foreign BCI and neurotechnology companies considering the China market.

  • The direction of travel is clearer, the details are not. A stated intent to build supporting innovative registration policies for BCI signals that the regulator is treating the field as a priority. It does not, on its own, change any filing requirement, and no BCI-specific approval timeline, acceptance number or product name has been published.
  • Classification and naming are the first practical questions. Because the regulator is unifying naming and classification rules for BCI, a company’s early task is to understand how its product would be classified and named under the Chinese system, since that determines the registration pathway.
  • Standards participation is a defined channel. With national and industry standards under development and an international-standard proposal submitted, there is an active standards-setting process. Foreign companies commonly monitor or participate in such processes through their China entities or industry associations, though the terms of participation follow the applicable standards rules.
  • Patent and intellectual-property positioning deserves early attention. BCI spans hardware, signal-processing algorithms and software. Companies usually review how their patent portfolio maps onto the Chinese classification and standards landscape before committing to a registration strategy. This is a commercial and legal planning point, not a statement of any regulatory preference.
  • Translation programmes are a signal, not a guarantee. The “Spring Rain Action” pipeline shows that a subset of high-end products is being routed into an expedited pre-review channel. Being in a high-priority field is relevant context, but selection for such programmes is a separate process.

Related considerations

For a foreign company, the sensible reading of these remarks is as a map of the regulator’s priorities rather than a set of entitlements. The registration figures show scale; the standards activity shows the field maturing towards defined technical requirements; and the “front-loading” language shows where facilitation effort is being directed. A company planning a China BCI strategy would typically combine this policy context with a product-specific review of classification, standards alignment, patent position and the appropriate registration pathway, and would confirm current requirements against the latest official publications before relying on any particular route.

Sources

  • 经济参考报 2026-10-08 报道(环球医药网转载)— 脑机接口纳入”十五五”规划与创新注册管理政策表态: https://www.qgyyzs.net/news/newshtml/hyxx/20261008090946.shtml
  • 中国政府网 — 未来产业与”十五五”规划政策背景: https://www.gov.cn/yaowen/liebiao/202610/content_7082824.htm
  • 中国网(受权发布)— 《关于发展新质生产力的意见》全文(含”前瞻布局未来产业”等产业定位表述): https://big5.china.com.cn/gate/big5/news.china.com.cn/2026-10/10/content_118727382.shtml

脑机接口医疗器械:中国创新注册管理政策方向

概述

2026年10月,2026国际生物医药产业创新北京论坛在北京亦庄举行。在该论坛的”神经调控与脑机接口技术产业发展论坛”上,国家药品监督管理局医疗器械注册管理司相关负责人就脑机接口医疗器械的监管现状与注册政策方向作了介绍。

据该负责人介绍,脑机接口已被纳入我国“十五五”规划、写入政府工作报告,明确作为未来产业予以布局。在此基础上,药监部门表示将配套创新注册管理政策,系统支持脑机接口医疗器械的研发与落地转化。

上述表态属政策方向性说明,而非新出台的规则。它描述的是现行医疗器械注册体系正如何向脑机接口领域倾斜,并以一组已公布的行业数据为依托,展示注册基数与创新支持工具的发展情况。

主要进展

该负责人的介绍将产业定位与具体数据结合在一起,勾勒出我国医疗器械注册的整体面貌。

  • 注册基数。 截至2026年7月底,全国有效医疗器械注册备案产品超过34.7万件,涵盖三类注册证、二类注册证及一类备案产品。
  • 年度批准量。 2025年,国家药监局共批准医疗器械注册14187项,同比增长8%。
  • 临床转化项目。 医疗器械临床创新成果转化“春雨行动”已征集400多个三类医疗器械产品,覆盖脑机接口、介入手术机器人、人工智能诊疗软件、高端植介入生物材料等高端赛道;已有22个优质项目纳入审评前置绿色通道。

综合来看,这组数据一方面说明注册管线规模庞大且仍在增长,另一方面也说明监管机构有意让部分高端产品以快于常规队列的方式通过审评。

标准先行:前置审评与标准工具箱

在注册数据之外,该负责人将监管机构的运行思路概括为“监管前置、标准先行”。

在标准方面,脑机接口领域已实现:

  • 累计发布3项行业标准;
  • 立项10项国家标准、3项行业标准;
  • 提交1项国际标准立项提案。

已发布的标准覆盖脑电采集、信号传输、运动意图解码、设备可靠性等核心技术环节。

在监管方面,相关做法包括:

  • 提前布局监管科学研究;
  • 对多款侵入式、非侵入式产品开展前置技术指导;
  • 统一产品命名与分类界定规则。

“标准先行”的逻辑对脑机接口这类技术尤为重要——医疗器械、消费级可穿戴设备与研究仪器之间的边界有时并不清晰。命名与分类界定规则,以及核心部件标准的建立,是产品得以进入明确注册路径的现实前提。

下一步监管方向

该负责人以总体表述方式提出了下一步方向:持续深化医疗器械审评审批制度改革,持续加大高端创新器械扶持力度。其中提到的具体举措包括:

  • 优化”全球新”产品审评机制;
  • 提供临床试验预审、技术咨询等前置服务;
  • 进而加速标杆产品上市。

这些属方向性表述,指示监管机构拟在何处集中便利化资源,并不等同于任何单一产品的审评条件。

对境外企业的实务意义

以下要点为分析性观察,并非官方承诺。它们描述的是该政策方向对考虑进入中国市场的境外脑机接口与神经技术企业可能意味着什么。

  • 方向更清晰,细节尚未明确。 表态提出将为脑机接口构建配套创新注册政策,说明监管机构将该领域视为优先方向。但这一表态本身并不改变任何申报要求,且截至目前并未公布脑机接口专属的审批时限、受理编号或产品名称。
  • 分类与命名是首要实务问题。 由于监管机构正在统一脑机接口的命名与分类界定规则,企业的早期工作之一是弄清其产品在中国体系下将被如何分类与命名,因为这决定了注册路径。
  • 参与标准化是一条既有通道。 随着国家标准与行业标准在研、国际标准提案已提交,标准化进程处于活跃状态。境外企业通常通过其在华主体或行业协会关注或参与此类进程,但参与条件须遵循适用的标准化管理规定。
  • 专利与知识产权布局宜及早关注。 脑机接口横跨硬件、信号处理算法与软件。企业通常会在确定注册策略前,先梳理其专利组合如何对应中国的分类与标准格局。这属商业与法律规划事项,并非监管倾向性表述。
  • 转化项目是信号,而非保证。 “春雨行动”管线显示,部分高端产品正被纳入审评前置快速通道。身处高优先级领域是相关背景,但能否入选此类项目是另一套独立程序。

相关考量

对境外企业而言,将上述表态理解为监管机构优先事项的路线图,比理解为一系列既得权益更为妥当。注册数据体现规模,标准化活动体现该领域正走向明确的技术要求,”前置”表述则体现便利化资源投入的方向。规划中国脑机接口战略的企业,通常会将这一政策背景与针对具体产品的分类、标准对齐、专利布局及相应注册路径评估结合起来,并在依赖任何具体路径前,依据最新官方发布确认现行要求。

来源

  • 经济参考报 2026-10-08 报道(环球医药网转载)— 脑机接口纳入”十五五”规划与创新注册管理政策表态: https://www.qgyyzs.net/news/newshtml/hyxx/20261008090946.shtml
  • 中国政府网 — 未来产业与”十五五”规划政策背景: https://www.gov.cn/yaowen/liebiao/202610/content_7082824.htm
  • 中国网(受权发布)— 《关于发展新质生产力的意见》全文(含”前瞻布局未来产业”等产业定位表述): https://big5.china.com.cn/gate/big5/news.china.com.cn/2026-10/10/content_118727382.shtml

Foreign Firms in China’s Standards Setting: Institutional Channels and Practical Pathways

  • A central policy document issued on 9 October 2026 encourages international standards organisations to develop in China and calls for actively building a global network of innovation cooperation.
    2026年10月9日印发的一份中央政策文件提出,鼓励国际标准组织等来华发展,并主动构建全球创新合作网络。
  • A separate central document on improving the market-access system states that key enterprises and research institutions should actively participate in international market-access rules and standards setting in a set of named frontier fields.
    另一份关于完善市场准入制度的中央文件提出,在若干前沿领域推动重点企业、研究机构等创新单元积极参与国际市场准入规则和标准制定。
  • China’s standards system has four levels: national standards, industry standards, local standards, and group standards together with enterprise standards.
    中国标准体系分为四个层级:国家标准、行业标准、地方标准,以及团体标准与企业标准。
  • Foreign-invested enterprises commonly take part as a drafting unit, through a domestic standardisation technical committee or industry association, or by contributing to group standards.
    外商投资企业参与标准化工作的常见方式包括:作为起草单位参与,通过国内标准化技术委员会或行业协会参与,或参与团体标准制定。
  • National standards published in foreign languages serve a translation and communication function for overseas headquarters and supply chains; their preparation and release follow the official standardisation workflow.
    国家标准外文版对境外总部与供应链起到翻译与沟通作用;其编制与发布遵循官方标准化工作流程。
  • Practical preparation typically involves identifying the committee that has jurisdiction, assembling technical materials and test data, and arranging intellectual-property and trade-secret protection during the drafting process.
    实务准备通常包括:明确归口的技术委员会、准备技术材料与试验验证数据,以及在起草过程中安排知识产权与商业秘密保护。
  • Participation channels and procedures are governed by the standardisation rules and the market-access framework in force; the applicable requirements should be confirmed against the official texts.
    参与的通道与程序以现行标准化制度与市场准入框架为准;适用要求应以官方文本确认。

Foreign Firms in China’s Standards Setting: Institutional Channels and Practical Pathways | 外商投资企业参与中国标准制定与国家标准外文版:制度通道与实务路径

Overview

On 9 October 2026, the Central Committee of the Communist Party of China and the State Council issued a policy document on developing new quality productive forces. Among its provisions, the document encourages foreign venture-capital institutions and international standards organisations to develop in China, and it calls for actively building a global network of innovation cooperation through platforms such as jointly built science parks, Belt and Road joint laboratories and international advanced-technology application centres. For foreign-invested enterprises, the reference to standards organisations is one of the clearer signals that participation in standards work sits inside the broader market-access picture rather than outside it.

A second central document, on improving the market-access system, addresses the same theme from the angle of rules and standards. In a set of named frontier fields, it provides that key enterprises, research institutions and relevant localities should establish collaborative models for cutting-edge global scientific research, actively participate in international market-access rules and standards setting, and promote the convenient and efficient application of innovation results in key fields. Read together, the two documents frame standards engagement as part of market access.

The four-tier standards system

China’s standards system has four levels: national standards, industry standards, local standards, and group standards together with enterprise standards. National standards are developed under the national standardisation framework. Industry standards are set within a sector. Local standards are issued at the provincial level. Group standards are adopted by social organisations such as associations, and enterprises may also adopt their own enterprise standards.

For a foreign-invested enterprise, the level at which it engages determines the channel it uses and the committee it deals with. Engagement is usually a matter of joining an existing drafting or consultation process rather than of initiating a standard, and the applicable procedures are set by the standardisation rules in force.

How foreign parties take part

The following channels are a practical summary of how foreign-invested enterprises commonly engage with standardisation under the current framework. This part is presented as practical orientation and is kept separate from the official policy text above.

  • Participation as a drafting unit. A foreign-invested enterprise may take part in the formulation or revision of a national standard or an industry standard as one of the drafting units, through the process that the relevant committee applies.
  • Participation through a committee or association. An enterprise may engage through a domestic standardisation technical committee or an industry association that takes part in the relevant field.
  • Participation in group standards. An enterprise may contribute to group standards adopted by social organisations, which sit alongside national, industry and local standards.

These channels describe the ordinary routes through which enterprises engage. They do not change the procedures or the authority that the standardisation rules assign.

National standards in foreign languages

National standards published in foreign languages serve a translation and communication function: they help overseas headquarters, group affiliates and supply-chain partners understand the technical requirements that apply in China. For a foreign-invested enterprise whose parent group works in a different language, a foreign-language edition of a relevant national standard can reduce the cost of internal alignment.

The preparation and release of foreign-language editions follow the official standardisation workflow. The existence of a foreign-language edition does not by itself alter the legal status of the underlying standard, and enterprises should treat the Chinese original as the reference text.

Practical preparation points

The following points are practical observations drawn from the current standardisation management system and market-access policy. They are separated from the official policy text above.

  • Identify the committee. Establish which standardisation technical committee has jurisdiction over the field, and confirm the applicable procedure for the level of standard involved.
  • Prepare technical materials. Assemble the technical documentation and the test or verification data that a drafting or consultation process is likely to require.
  • Manage intellectual property and trade secrets. Because drafting involves sharing technical detail, arrange in advance how intellectual property and confidential commercial information will be handled during the process.

Questions enterprises commonly raise

  • “Can a foreign-invested enterprise lead a Chinese national standard?” The policy texts encourage participation; they do not confer a right to lead or direct the formulation of a national standard. Participation follows the applicable standardisation procedure, and the role an enterprise may take is determined within that procedure.
  • “Does a foreign-language edition change what applies?” No. The foreign-language edition is a translation and communication tool. The Chinese text of the standard remains the reference, and the legal status of the standard is unchanged.
  • “Is standards participation a route around sector restrictions?” No. Where a sector falls under the negative list for foreign investment or under specific licensing, those access rules continue to apply independently of any standards work.

The connection to market access

The market-access document and the new-quality-productivity document approach standards from two directions. The market-access document ties standards participation to the coordination of frontier research across enterprises, institutions and localities. The new-quality-productivity document places standards organisations within the set of actors encouraged to develop in China, alongside foreign venture-capital institutions, and links them to a global innovation-cooperation network. For an enterprise, the practical consequence is that standards engagement is best planned together with the market-access and research-collaboration questions it may already be pursuing, rather than in isolation.

Related considerations

Participation in standards work is distinct from market access in the narrower sense. The fields named in the market-access document describe where coordinated research and standards engagement is encouraged; they do not by themselves change the entry conditions for any sector. Where a sector is subject to the negative list for foreign investment or to specific licensing, the applicable access requirements continue to be governed by those rules. Enterprises should confirm sector-specific conditions against the official texts in force, and treat the practical points above as orientation rather than as a statement of entitlement.

Sources

  • 中国政府网 — 《关于发展新质生产力的意见》: https://www.gov.cn/yaowen/liebiao/202610/content_7082824.htm
  • 洛浦县人民政府网 — 《关于完善市场准入制度的意见》: https://www.xjlpx.gov.cn/xinxigongkai/show.php?itemid=10709
  • 中国网 — 《关于发展新质生产力的意见》受权发布全文: https://big5.china.com.cn/gate/big5/news.china.com.cn/2026-10/10/content_118727382.shtml

外商投资企业参与中国标准制定与国家标准外文版:制度通道与实务路径

概述

2026年10月9日,中共中央、国务院印发关于发展新质生产力的政策文件。该文件在相关条款中提出,鼓励外资创业投资机构、国际标准组织等来华发展,并推动共建科技园区、“一带一路”联合实验室、国际先进技术应用推进中心等平台,主动构建全球创新合作网络。对外商投资企业而言,其中对标准组织的表述,是较为清晰的一个信号:参与标准化工作属于更广义市场准入图景的一部分,而非其外。

另一份关于完善市场准入制度的中央文件,从规则与标准的角度处理同一主题。该文件在若干前沿领域提出,推动重点企业、研究机构等创新单元和有关地方建立相关领域全球前沿科学研究协同模式,积极参与国际市场准入规则和标准制定,推动重点领域创新成果便捷高效应用。两份文件合起来看,把参与标准化放在市场准入的框架之内。

四层标准体系

中国标准体系分为四个层级:国家标准、行业标准、地方标准,以及团体标准与企业标准。国家标准在国家标准化框架下制定;行业标准在行业范围内确定;地方标准在省级层面发布;团体标准由协会等社会团体采用,企业也可采用自身的企业标准。

对外商投资企业而言,参与在哪一层级,决定了其使用的通道和对接的技术委员会。参与通常意味着加入既有的起草或征求意见流程,而非发起一项标准;适用的程序由现行标准化制度确定。

境外主体如何参与

以下通道,是在现行框架下对外商投资企业参与标准化常见方式的实务归纳。这一部分作为实务指引呈现,与上文官方政策原文分开。

  • 作为起草单位参与。 外商投资企业可以按照相关技术委员会适用的流程,作为起草单位之一参与国家标准或行业标准的制定、修订。
  • 通过技术委员会或行业协会参与。 企业可以通过参与相关领域工作的国内标准化技术委员会或行业协会开展参与。
  • 参与团体标准。 企业可以参与由社会团体采用的团体标准,团体标准与国家标准、行业标准、地方标准并列。

这些通道描述的是企业参与的常规路径,并不改变标准化制度所规定的程序或权限。

国家标准外文版

国家标准外文版起到翻译与沟通的作用:帮助境外总部、集团关联机构与供应链伙伴理解在中国适用的技术要求。对外商投资企业而言,若其母公司集团使用不同语言工作,相关国家标准的外文版可以降低内部对齐的成本。

外文版的编制与发布遵循官方标准化工作流程。外文版的存在本身并不改变其所对应标准的法律地位,企业应以中文原文作为参照文本。

实务准备要点

以下要点,是根据现行标准化管理制度与市场准入政策整理的实务观察,与上文官方政策原文分开。

  • 明确归口委员会。 确认所在领域由哪一标准化技术委员会归口,并确认所涉标准层级适用的程序。
  • 准备技术材料。 汇集起草或征求意见流程可能需要的技术文件与试验、验证数据。
  • 管理知识产权与商业秘密。 由于起草过程涉及技术细节的交流,应提前安排知识产权与保密商业信息在该过程中的处理方式。

企业常见疑问

  • “外商投资企业能否主导一项中国国家标准?” 政策文本鼓励的是参与,并未赋予主导或指挥国家标准制定的权利。参与依照适用的标准化程序进行,企业能够承担的角色在该程序内确定。
  • “外文版是否改变适用的内容?” 不改变。外文版是翻译与沟通工具。标准的中文文本仍为参照,标准的法律地位不变。
  • “参与标准化是否是绕开行业限制的途径?” 不是。某一行业若属于外商投资负面清单管理范围或适用特定许可,其准入规则仍独立适用,不因标准化工作而改变。

与市场准入的关联

市场准入文件与关于发展新质生产力的文件,从两个方向处理标准问题。市场准入文件把标准参与同企业、机构与地方之间的前沿研究协同联系起来。关于发展新质生产力的文件,则把标准组织列入鼓励来华发展的主体范围,与外资创业投资机构并列,并将其与全球创新合作网络相连。对企业而言,实际结果在于:参与标准化,宜与其可能已在推进的市场准入、研究协同问题一并规划,而非孤立处理。

相关考量

参与标准化工作,与狭义的市场准入有所区别。市场准入文件所列领域,说明的是鼓励协同研究与标准参与的方向;其本身并不改变任何行业的准入条件。某一行业若属于外商投资负面清单管理范围,或适用特定许可,其准入要求仍由相应规则管辖。企业应结合现行有效的官方文本确认分行业的具体条件,并将上文实务要点视为指引,而非权利主张。

来源

  • 中国政府网 — 《关于发展新质生产力的意见》: https://www.gov.cn/yaowen/liebiao/202610/content_7082824.htm
  • 洛浦县人民政府网 — 《关于完善市场准入制度的意见》: https://www.xjlpx.gov.cn/xinxigongkai/show.php?itemid=10709
  • 中国网 — 《关于发展新质生产力的意见》受权发布全文: https://big5.china.com.cn/gate/big5/news.china.com.cn/2026-10/10/content_118727382.shtml

Traditional Chinese Medicine Knowledge Protection: What the September 2026 Draft Regulation Means for Foreign Pharmaceutical and Healthcare Companies

  • On 18 September 2026, the State Council executive meeting reviewed and approved in principle the Draft Regulation on the Protection of Traditional Chinese Medicine Knowledge, describing traditional Chinese medicine theory, techniques and formulas as important resources for China’s own innovation and calling for comprehensive strengthening of protection and management.
    2026年9月18日,国务院常务会议审议通过《中医药传统知识保护条例(草案)》,会议指出中医药理论、技术和方药是我国自主创新的重要资源,要全面加强保护管理。
  • The regulation is to establish a protection system for traditional Chinese medicine knowledge: after registration and review-based recognition, a holder enjoys rights to indicate identity, to transmit and use, to informed consent, to benefit sharing, to integrity protection and to require disclosure of source, while medical institutions are encouraged to proactively investigate and develop proven formulas, secret formulas and techniques.
    条例将建立中医药传统知识保护制度:经登记并审核认定后,持有人享有表明身份、传承使用、知情同意、利益分享、完整保护、要求说明来源等权利,并鼓励医疗机构主动调查发现中医药验方、秘方和技法并进行开发研究。
  • The draft has not been published in full, so no article numbers, effective date, registration procedure or recognition thresholds are available; planning should rest on the official record as it appears.
    草案尚未公布全文,条款编号、生效日期、登记程序与认定门槛均无从确认;相关规划应以官方后续发布为准。
  • The IP Protection and Application 15th Five-Year Plan (State Council document No. 30 of 2026, issued on 27 July 2026) already lists “issuing the Regulation on the Protection of Traditional Chinese Medicine Knowledge” and strengthening access and benefit-sharing systems for traditional knowledge and folk literature and art.
    《知识产权保护和运用”十五五”规划》(国发〔2026〕30号,国务院2026年7月27日印发)已明确”出台中医药传统知识保护条例”,并加强传统知识、民间文艺等获取和惠益分享制度建设。
  • The same Plan directs improvement of intellectual property protection rules for algorithms and AI-generated output and exploration of data intellectual property protection rules, matters relevant to digital health and AI-assisted research.
    同一规划还提出完善算法、人工智能生成物等知识产权保护规则,探索构建数据知识产权保护规则,与数字健康及人工智能辅助研究密切相关。
  • The revised Trademark Law was adopted on 26 June 2026 and takes effect on 1 January 2027; it writes the principle of good faith into the law and targets bad-faith filings, trademark hoarding and agency conduct.
    新修订《商标法》于2026年6月26日通过、2027年1月1日施行,将诚实信用原则写入法律,并针对恶意抢注、商标囤积及代理行为作出规范。

Traditional Chinese Medicine Knowledge Protection: What the September 2026 Draft Regulation Means for Foreign Pharmaceutical and Healthcare Companies | 中医药传统知识保护:2026年9月国务院常务会议审议通过条例草案对外资医药与大健康企业的意义

Overview

On 18 September 2026, the State Council executive meeting reviewed and approved in principle the Draft Regulation on the Protection of Traditional Chinese Medicine Knowledge. In the official account, traditional Chinese medicine theory, techniques and formulas are described as important resources for China’s own innovation, and the requirement is to comprehensively strengthen their protection and management. The draft has not yet been published in full.

For foreign pharmaceutical, healthcare and wellness companies working in or with China, the development matters for a practical reason. It sits alongside a wider set of intellectual property measures that took effect or moved through the system in 2026, from the revised Trademark Law to the IP Protection and Application 15th Five-Year Plan. Together they shape how traditional knowledge, research collaboration and brand assets are documented and defended.

This article sets out the official wording, the protection system as described, the institutional arrangements in the 15th Five-Year Plan, and the practical points foreign companies may wish to consider. It deliberately does not speculate beyond the official record.

The September 2026 decision

The executive meeting approved the draft and set the direction of policy. Traditional Chinese medicine theory, techniques and formulas are treated as important resources for China’s own innovation, and the task set is to comprehensively strengthen protection and management.

The regulation is to establish a protection system for traditional Chinese medicine knowledge. Under that system, after registration and review-based recognition, a holder enjoys a set of rights: to indicate identity, to transmit and use the knowledge, to give informed consent, to share in benefits, to integrity protection, and to require disclosure of source.

The official account also encourages medical institutions to proactively investigate and discover traditional Chinese medicine proven formulas, secret formulas and techniques, and to carry out development and research on them.

Because the full text has not been published, no article numbers, effective date, registration procedure or definitional thresholds are available. Companies should treat any such details as pending until an official release appears, and should not rely on descriptions that circulate without an official source.

What the 15th Five-Year Plan already provides

The draft regulation is not an isolated initiative. The IP Protection and Application 15th Five-Year Plan (State Council document No. 30 of 2026, issued on 27 July 2026) had already placed it within a wider programme.

The Plan calls for accelerating improvement of the patent-related legal system, for comprehensively revising the Trademark Law and its implementing regulations, and for issuing the Regulation on the Protection of Traditional Chinese Medicine Knowledge. It also directs strengthening access and benefit-sharing systems for traditional knowledge, folk literature and art, and improving intellectual property protection rules for algorithms and AI-generated output as well as for platform-economy development. It further calls for exploring data intellectual property protection rules.

The Plan sets out milestones. By 2030, China’s comprehensive intellectual property strength and international competitiveness are to be further enhanced, with decisive progress in building an intellectual property power. Looking to 2035, comprehensive intellectual property competitiveness is to rank among the world’s leading.

For a company mapping its China research and brand strategy, the Plan is useful because it shows the direction of travel across several instruments at once rather than the detail of a single new rule.

Adjacent intellectual property developments in 2026

A nationwide briefing tour on new intellectual property rules began in Jinan on 20 September 2026, covering the Shandong and Anhui region. The briefings addressed three instruments.

The revised Trademark Law writes the principle of good faith into the law, targets bad-faith filings and the hoarding of trademarks, tightens supervision of trademark agencies and strengthens industry credit constraints. It was adopted on 26 June 2026 and takes effect on 1 January 2027.

The revised Regulation on the Protection of Layout Designs of Integrated Circuits brings layout designs performing functions such as integrated photonics and quantum into the statutory scope of protection and establishes an originality declaration system.

The revised Measures for the Prioritised Examination of Patents steer prioritised examination resources toward emerging industries and key core technology programmes, and establish a central-local coordination mechanism.

Read together with the traditional knowledge regulation, these measures point in a consistent direction: more explicit documentation of what is claimed, who holds it and where it came from.

Practical implications for foreign pharmaceutical and healthcare companies

Due diligence on traditional knowledge. Where a project touches formulas, techniques or sources of traditional knowledge, the rights described in the official account — identity, transmission and use, informed consent, benefit sharing, integrity protection and disclosure of source — suggest that provenance and consent questions may become part of the record. Companies may wish to document how a formula or technique was obtained and on what terms.

Collaboration agreements. Research with hospitals, institutes and practitioners should be documented, with clarity on background and foreground rights, on publication, and on how jointly created results are handled.

Patent and brand layout. The Plan’s direction on patents and the revised Trademark Law both reward early, well-documented filing strategies. A portfolio that depends on distinctive names and marks should be checked against the good-faith and bad-faith filing provisions as they take effect.

Digital and AI-related work. The Plan’s references to algorithms, AI-generated output and data intellectual property are relevant to digital health, AI-assisted screening and data-driven research, where ownership of outputs and datasets is often unsettled.

Watch the official record. Because the draft regulation is not yet published in full, the specific registration route, recognition criteria and benefit-sharing mechanics remain to be seen. Planning should be revisited when the text and any supporting measures are released.

Related considerations

Foreign-invested companies in the healthcare and wellness sectors already work within sector-specific rules on drugs, devices, healthcare services and advertising. The traditional knowledge regulation adds a knowledge-protection layer rather than replacing those rules. Keeping the two layers distinct — what may be made and sold, and what knowledge may be used and on what terms — helps avoid conflating a licensing question with a market-access question.

Sources

  • 国家知识产权局(《知识产权保护和运用”十五五”规划》专栏): https://www.cnipa.gov.cn/col/col3692/index.html
  • 酒泉市公安局(《知识产权保护和运用”十五五”规划》国发〔2026〕30号全文转载): https://gaj.jiuquan.gov.cn/gaj/c106483/202609/856895252998428d9990e67d9af39108.shtml
  • 国家知识产权局(官网,9月工作动态): https://www.cnipa.gov.cn/?filter=0
  • 大众网滨州(知识产权新规全国巡回宣贯,9月20日济南,9-23): https://www.toutiao.com/article/7688564714451780098/
  • 中国政府网: https://www.gov.cn/

中医药传统知识保护:2026年9月国务院常务会议审议通过条例草案对外资医药与大健康企业的意义

概述

2026年9月18日,国务院常务会议审议通过《中医药传统知识保护条例(草案)》。官方表述指出,中医药理论、技术和方药是我国自主创新的重要资源,要全面加强保护管理。该草案尚未公布全文。

对在华开展业务或与中国合作的外资医药、医疗健康与大健康企业而言,这一进展具有现实意义:它与2026年已经施行或正在推进的一揽子知识产权举措并列,从新修订《商标法》到《知识产权保护和运用”十五五”规划》,共同影响传统知识、研究协作与品牌资产的记录与维护方式。

本文梳理官方原文表述、条例拟确立的保护制度、规划中的制度安排,以及外资企业可能关注的实务要点,并刻意不作出超出官方记录范围的推断。

2026年9月的决定

国务院常务会议审议通过草案并确定了政策方向。中医药理论、技术和方药被视为我国自主创新的重要资源,任务要求是全面加强保护管理。

条例将建立中医药传统知识保护制度。在该制度下,经登记并审核认定后,持有人享有一组权利:表明身份、传承使用、知情同意、利益分享、完整保护、要求说明来源。

官方表述还鼓励医疗机构主动调查发现中医药验方、秘方和技法,并进行开发研究。

由于全文尚未公布,条款编号、生效日期、登记程序与认定门槛均无从确认。企业宜将此类细节视为待定,直至官方发布为止,不应依赖没有官方出处的描述。

“十五五”规划已作出的安排

该条例草案并非孤立举措。《知识产权保护和运用”十五五”规划》(国发〔2026〕30号,国务院2026年7月27日印发)已把它纳入更宏大的部署。

规划提出加快完善专利相关法律制度,推动商标法及其实施条例全面修改,并出台中医药传统知识保护条例。规划还提出加强传统知识、民间文艺等获取和惠益分享制度建设,完善算法、人工智能生成物以及与平台经济发展相关的知识产权保护规则,并探索构建数据知识产权保护规则。

规划设定了节点目标:到2030年,知识产权综合实力和国际竞争力进一步增强,知识产权强国建设取得决定性进展;展望2035年,知识产权综合竞争力跻身世界前列。

对正在规划中国研究与品牌战略的企业而言,该规划的价值在于,它一次性展示了多项制度工具的共同走向,而不只是一条新规的细节。

2026年相邻的知识产权进展

2026年9月20日,知识产权新规全国巡回宣贯在济南启动,覆盖山东、安徽片区。宣贯围绕三件法规展开。

新修订《商标法》将诚实信用原则写入法律,遏制恶意抢注、囤积商标,严格商标代理监管,强化行业信用约束。该法于2026年6月26日通过,2027年1月1日施行。

新修订《集成电路布图设计保护条例》将集成光子、量子等功能的集成电路布图设计纳入法定保护范围,并建立独创性声明制度。

修订后的《专利优先审查管理办法》使优先审查资源向新兴产业、关键核心技术攻关倾斜,并建立央地协同机制。

与中医药传统知识保护条例合并来看,这些举措指向一个一致的方向:对主张什么、由谁持有、来自何处作出更明确的记录。

对外资医药与大健康企业的实务影响

传统知识尽职调查。 当项目涉及方药、技法或传统知识来源时,官方表述中的权利——表明身份、传承使用、知情同意、利益分享、完整保护、要求说明来源——提示来源与同意问题可能进入记录范围。企业宜留存取得方药或技法的途径与条件的书面材料。

合作协议。 与医院、科研院所及从业者的研究合作应有书面安排,就背景权利与前景权利、发表,以及共同形成成果的处理作出清晰约定。

专利与品牌布局。 规划在专利方面的方向与新修订《商标法》都倾向于奖励尽早且记录充分的申请策略。依赖独特名称与标识的资产组合,宜在新法施行后比照诚实信用与恶意申请相关条款作一次核对。

数字与人工智能相关工作。 规划中关于算法、人工智能生成物与数据知识产权的表述,与数字健康、人工智能辅助筛查及数据驱动研究相关,而这些领域中成果与数据集的归属往往并不确定。

关注官方记录。 由于条例草案尚未公布全文,具体登记路径、认定标准与惠益分享机制仍有待观察。待文本及配套办法发布后,宜重新审视既有规划。

相关考虑

医药与大健康领域的外商投资企业,本就需遵循药品、器械、医疗服务与广告等分行业规则。中医药传统知识保护条例增加的是一个知识保护层面,而非取代上述规则。把两个层面区分开来——可以制造与销售什么,以及可以何种条件使用何种知识——有助于避免把许可问题与市场准入问题混为一谈。

来源

  • 国家知识产权局(《知识产权保护和运用”十五五”规划》专栏):https://www.cnipa.gov.cn/col/col3692/index.html
  • 酒泉市公安局(《知识产权保护和运用”十五五”规划》国发〔2026〕30号全文转载):https://gaj.jiuquan.gov.cn/gaj/c106483/202609/856895252998428d9990e67d9af39108.shtml
  • 国家知识产权局(官网,9月工作动态):https://www.cnipa.gov.cn/?filter=0
  • 大众网滨州(知识产权新规全国巡回宣贯,9月20日济南,9-23):https://www.toutiao.com/article/7688564714451780098/
  • 中国政府网:https://www.gov.cn/

Services Opening After the National Services Conference: Foreign-Invested Value-Added Telecom Pilots Reach 221

  • In early April 2026 China convened a National Services Conference; afterwards the National Development and Reform Commission, working with 40 departments, set out 131 priority tasks for 2026 and 2027.
    2026年4月初,中国召开全国服务业大会;会后国家发展改革委会同40个部门,梳理确定2026、2027两年131项重点任务。
  • Within half a year departments had issued 81 supporting measures, more than sixty per cent of the priority work showed clear progress, and 27 provinces had held their own provincial services conferences.
    半年内,有关部门已出台81项配套举措,超六成重点工作取得明显进展,全国已有27个省份召开省级服务业大会。
  • New foreign-invested value-added telecom business pilots rose by 91 to a total of 221, after the first batch was launched in February 2025.
    新增外资企业增值电信业务经营试点91家,总数达221家;首批试点于2025年2月启动。
  • In the first half of 2026 services contributed 66.1 per cent of China’s economic growth, up 5.9 percentage points year on year, and the services business activity expectation index has stayed above 55 per cent for five consecutive months since April.
    2026年上半年,服务业对中国经济增长的贡献率达66.1%,较上年同期提高5.9个百分点;4月以来服务业业务活动预期指数连续5个月在55%以上。
  • In the first seven months of 2026 spending in China by overseas visitors rose 27.8 per cent year on year and services exports rose 17.1 per cent, narrowing the services trade deficit by about 16 per cent.
    2026年前7个月,境外人员在华消费同比增长27.8%,服务出口同比增长17.1%,带动服务贸易逆差收窄约16%。
  • Services now account for about seventy per cent of foreign investment actually used, according to Wang Ya of the Ministry of Commerce’s foreign investment administration.
    据商务部外国投资管理司负责人王亚介绍,服务业在实际使用外资中的比重已达七成。
  • The opening programme rests on three tracks — widening market access, guiding foreign investment into producer and modern services, and pilot demonstration — including removing foreign equity caps on app stores and internet access in telecom, supporting international factoring, and encouraging cross-border settlement through the multilateral central bank digital currency bridge and digital RMB channels.
    开放部署有三大方向:放宽市场准入、引导外资投向生产性服务业和现代服务业、试点示范;其中包括电信领域取消应用商店、互联网接入等服务业务外资股比限制,支持探索国际保理业务,鼓励依托多边央行数字货币桥和数字人民币双边跨境业务渠道开展跨境贸易和投融资结算。

Services Opening After the National Services Conference: Foreign-Invested Value-Added Telecom Pilots Reach 221 | 全国服务业大会后服务业扩大开放:外资增值电信试点增至221家

Overview

At a special press conference in late September 2026, the National Development and Reform Commission (NDRC) set out the progress of China’s drive to expand and upgrade services. The account begins with a National Services Conference held in early April 2026 and runs through the measures taken since. For foreign investors, the headline number is the growth of the foreign-invested value-added telecom business pilot, which has risen to 221 enterprises.

The press conference is a stock-take rather than a new rule. Its value lies in the official data it supplies: how many priority tasks have been set, how many supporting measures have followed, how many provinces have convened their own conferences, and how the services sector has performed. Together these figures describe the operating environment into which foreign-invested services businesses are being invited.

This note sets out the national push, the telecom pilot numbers, the macroeconomic picture, the three tracks of opening, and the practical points a foreign investor would weigh. It deals with services opening and does not cover the separate cash-pooling or manufacturing regimes.

The national push: conference, tasks and supporting measures

The sequence starts with the National Services Conference in early April 2026. After the conference, the NDRC, working with 40 departments, identified 131 priority tasks covering the two years 2026 and 2027. The task list is the organising device: it turns the conference’s direction into a set of time-bound items owned by named departments.

Within half a year, departments had issued 81 supporting measures, and more than sixty per cent of the priority work showed clear progress. At the provincial level, 27 provinces had convened their own services conferences, which is a signal that the agenda is being carried down rather than left at the centre.

For a foreign-invested services business, the structure matters as much as the numbers. A task list with named owners and supporting measures is the machinery through which access commitments reach the level at which licences and approvals are actually handled.

Foreign-invested value-added telecom pilots reach 221

The most concrete indicator for foreign investors is the value-added telecom business pilot. The first batch was launched in February 2025. Since then, 91 new foreign-invested enterprises have been added, bringing the total to 221.

Value-added telecom services are the layer of the telecom market above basic carriage — services such as app stores, internet access and related offerings. Because telecom has historically been a sector with foreign equity restrictions, the pilot is the route through which foreign-invested participation is tested. The growth from the first batch to 221 enterprises is the clearest official measure of how that route has been used.

Services as the main growth engine

The press conference also supplied the macroeconomic backdrop.

In the first half of 2026, services contributed 66.1 per cent of China’s economic growth, up 5.9 percentage points on the same period a year earlier. Since April, the services business activity expectation index has stayed above 55 per cent for five consecutive months — a level that indicates expansion in the sector’s own expectations.

Cross-border services tell a similar story. In the first seven months of 2026, spending in China by overseas visitors rose 27.8 per cent year on year, and China’s services exports rose 17.1 per cent. The two flows together narrowed the services trade deficit by about 16 per cent.

For foreign investment, the sector’s weight is direct: according to Wang Ya of the Ministry of Commerce’s foreign investment administration, services now account for about seventy per cent of foreign investment actually used. In other words, services is no longer a marginal category in inbound investment but the dominant one.

Three tracks of opening

The opening programme is described as resting on three tracks.

Widening market access. Since 2024, pilots to expand opening have been run in selected regions in three fields: cloud computing, wholly foreign-owned hospitals, and biotechnology. The plan is to steadily expand opening pilots in vocational skills training institutions, vocational colleges, and high-level science, engineering, agriculture and medical universities. Foreign institutions are to be supported in using treasury bond futures and other risk-management tools, and in lawfully conducting fund investment advisory business.

Guiding the direction of foreign investment. Foreign investment is to be guided toward producer services and modern services. The Catalogue of Industries for Encouraging Foreign Investment is to be revised and reissued. The tax exemption on imported research supplies for foreign-invested research and development centres is to be continued. Functional institutions such as regional headquarters and R&D centres are to be attracted.

Pilot demonstration. Since 2025, nine new cities have been added to the comprehensive pilot for expanded services opening. In telecom, the foreign equity caps on app stores, internet access and similar services have been removed. In healthcare, foreign doctors are supported in opening clinics, and overseas medical professionals in short-term practice. In finance, international factoring is to be explored, and cross-border trade and investment settlement is encouraged through the multilateral central bank digital currency bridge and digital RMB bilateral cross-border channels.

Alongside these, technology business incubators were for the first time graded as excellent-class or standard-class, and a first list of 416 was published. The first national platform for foreign-related legal services is being built.

Practical implications for foreign investors

Three practical points follow.

First, telecom is worth a fresh look. With foreign equity caps removed on app stores, internet access and similar services, and with 221 enterprises already in the pilot, a foreign-invested digital or e-commerce business that had assumed telecom was closed to it may find a route through the pilot.

Second, the direction of encouragement is now explicit. Producer services and modern services are named as the target, the encouraging catalogue is being revised, and the R&D-centre import exemption is being continued. A group planning a regional headquarters or a research centre has a clearer picture of where policy support points.

Third, the settlement and risk-management toolkit is widening. Support for using treasury bond futures, for fund investment advisory, and for cross-border settlement via the digital currency bridge and digital RMB channels expands what a foreign-invested financial or services entity can do onshore.

A foreign-invested services group considering China would typically map its activity against the three tracks: whether its sector has an access pilot, whether it fits the encouraged direction, and whether it can use the financial tools now on offer. The figures from the press conference — 221 telecom pilots, 66.1 per cent growth contribution, seventy per cent of inbound investment — are the official markers of how far that opening has already run.

Sources

  • 证券时报 — 国家发展改革委专题新闻发布会介绍服务业扩能提质进展: https://www.stcn.com/article/detail/4202097.html
  • 中新社 — 全国服务业大会以来服务业扩大开放进展报道: https://www.toutiao.com/article/7690849308291154472/
  • 南方都市报 — 外资企业增值电信业务经营试点增至221家报道: https://www.163.com/dy/article/L807V6N105129QAF.html
  • 金融界 — 服务业扩能提质新闻发布会数据报道: https://www.163.com/dy/article/L8042FLD0519QIKK.html
  • 商务部 — 政策发布栏目: https://www.mofcom.gov.cn/zcfb/

全国服务业大会后服务业扩大开放:外资增值电信试点增至221家

概述

在2026年9月下旬的一场专题新闻发布会上,国家发展改革委介绍了中国推动服务业扩能提质的进展。介绍从2026年4月初召开的全国服务业大会开始,延伸至此后采取的举措。对来华投资者而言,最醒目的数字是外资企业增值电信业务经营试点的增长——总数已达221家。

这场发布会是一次阶段性盘点,而非出台新规则。其价值在于提供了官方数据:确定了多少项重点任务、随后出台了多少项配套举措、有多少省份召开了省级服务业大会,以及服务业的表现如何。这些数据共同描述了外资服务企业被邀请进入的经营环境。

本文梳理国家层面的推动、电信试点的数字、宏观表现、三大开放方向,以及来华投资者会权衡的实务要点。本文只涉及服务业开放,不涉及跨境资金池或制造业等其他制度安排。

国家层面的推动:大会、任务与配套举措

这一进程从2026年4月初的全国服务业大会开始。会后,国家发展改革委会同40个部门,梳理确定了覆盖2026、2027两年的131项重点任务。任务清单是组织装置:它把大会的方向转化为由具体部门负责、有明确时限的事项。

半年内,有关部门已出台81项配套举措,超六成重点工作取得明显进展。在省级层面,全国已有27个省份召开省级服务业大会,这一信号说明议程正在向下传导,而不是停留在中央层面。

对在华外资服务企业而言,结构与数字同样重要。一份有明确责任主体、有配套举措支撑的任务清单,正是准入承诺传导至许可证与审批实际办理层级的机制。

外资增值电信业务经营试点增至221家

对来华投资者而言最具体的指标,是增值电信业务经营试点。首批试点于2025年2月启动。此后新增外资企业91家,总数达到221家。

增值电信服务是电信市场在基础承载之上的一层业务,包括应用商店、互联网接入以及相关服务。由于电信历来是设有外资股比限制的领域,试点是测试外资参与的一条路径。从首批到221家企业,是官方衡量这条路径使用情况的最清晰指标。

服务业是主要增长引擎

发布会还提供了宏观背景。

2026年上半年,服务业对中国经济增长的贡献率达66.1%,较上年同期提高5.9个百分点。自4月以来,服务业业务活动预期指数连续5个月在55%以上——这一水平表明该行业自身预期处于扩张区间。

跨境服务也呈现相似图景。2026年前7个月,境外人员在华消费同比增长27.8%,中国服务出口同比增长17.1%。两项流量共同带动服务贸易逆差收窄约16%。

对外资而言,该行业的权重是直接的:据商务部外国投资管理司负责人王亚介绍,服务业在实际使用外资中的比重已达七成。换言之,服务业在来华投资中已不再是边缘类别,而是占据主导。

三大开放方向

开放部署被概括为三大方向。

放宽市场准入。 2024年以来,已在部分地区率先开展云计算、独资医院、生物技术3个领域的扩大开放试点。下一步将稳步扩大在职业技能培训机构、职业院校、高水平理工农医类大学的对外开放试点。支持更多外资机构利用国债期货等风险管理工具,依法开展基金投资顾问业务。

引导外资投向。 引导外资投向生产性服务业和现代服务业。修订出台新版《鼓励外商投资产业目录》。延续外资研发中心进口科研用品免税政策。吸引地区总部、研发中心等功能性机构。

试点示范。 2025年以来,新增9个服务业扩大开放综合试点城市。电信领域取消应用商店、互联网接入等服务业务的外资股比限制。医疗领域支持外籍医生开设诊所、境外医疗专业技术人员短期执业。金融领域支持探索国际保理业务,鼓励依托多边央行数字货币桥和数字人民币双边跨境业务渠道开展跨境贸易和投融资结算。

除上述部署之外,科技企业孵化器首次分为卓越级、标准级认定,并发布第一批416家名单。首个全国性涉外法律服务平台正在建设。

对来华投资者的实务含义

有三点实务含义。

其一,电信领域值得重新审视。随着应用商店、互联网接入等服务业务的外资股比限制被取消,且试点已有221家企业,一家此前认为电信领域对其关闭的外资数字或电商企业,可能通过试点找到路径。

其二,鼓励方向已经明确。生产性服务业和现代服务业被列为目标,鼓励目录正在修订,研发中心进口免税政策延续。一家规划地区总部或研发中心的集团,对政策支持的落点有了更清晰的判断。

其三,结算与风险管理工具箱在扩大。支持使用国债期货、支持基金投资顾问业务、鼓励依托数字货币桥与数字人民币渠道开展跨境结算,都扩展了在华外资金融或服务主体可以开展的业务范围。

一家考虑进入中国的外资服务集团,通常会把自己的业务与三大方向逐一对照:所在领域是否有准入试点、是否符合鼓励方向、能否使用现有金融工具。发布会给出的数字——221家电信试点、66.1%的增长贡献率、七成的来华投资占比——是衡量开放已推进到何种程度的官方标记。

来源

  • 证券时报 — 国家发展改革委专题新闻发布会介绍服务业扩能提质进展: https://www.stcn.com/article/detail/4202097.html
  • 中新社 — 全国服务业大会以来服务业扩大开放进展报道: https://www.toutiao.com/article/7690849308291154472/
  • 南方都市报 — 外资企业增值电信业务经营试点增至221家报道: https://www.163.com/dy/article/L807V6N105129QAF.html
  • 金融界 — 服务业扩能提质新闻发布会数据报道: https://www.163.com/dy/article/L8042FLD0519QIKK.html
  • 商务部 — 政策发布栏目: https://www.mofcom.gov.cn/zcfb/

China’s 15th Five-Year Plan for Intelligent Connected NEVs: Targets, Guardrails and What It Means for Foreign Investors

  • Nine departments led by the Ministry of Industry and Information Technology have jointly issued the 15th Five-Year Plan for the Intelligent Connected New Energy Vehicle Industry; the co-issuing bodies are the National Development and Reform Commission, the Ministry of Public Security, the Ministry of Transport, the Ministry of Commerce, the Ministry of Natural Resources, the Ministry of Housing and Urban-Rural Development, the State Administration for Market Regulation and the Cyberspace Administration of China.
    工业和信息化部会同国家发展改革委、公安部、交通运输部、商务部、自然资源部、住房和城乡建设部、市场监管总局、国家网信办(共九部门)联合印发《智能网联新能源汽车产业发展”十五五”规划》。
  • The 2030 targets are that China’s whole-industry-chain advantage in intelligent connected new energy vehicles is further consolidated and the country joins the ranks of the world’s automotive powers; new energy passenger vehicles are to reach 70% of new-vehicle sales in their respective segments and commercial vehicles 40%; and vehicles with autonomous-driving functions are to achieve large-scale application.
    到 2030 年,我国智能网联新能源汽车全产业链优势进一步巩固,进入世界汽车强国行列;国内新能源乘用车在各自领域新车总销量占比达 70%、商用车达 40%;具备自动驾驶功能的汽车实现规模应用。
  • The plan deploys five areas and 17 key tasks — raising technological innovation capability, upgrading the industrial system, promoting cross-sector integration, building a scientific and efficient industry-governance system, and opening a new chapter in global industrial cooperation — supported by four major projects and three priority actions.
    《规划》部署 5 方面 17 项重点任务:提高技术创新能力、推动产业体系优化升级、促进跨界融合发展、构建科学高效的行业治理体系、开创全球产业合作新局面;并配套 4 项重大工程与 3 项重点行动。
  • Capacity early-warning and control is written into an industry five-year plan for the first time: the plan tightens the conditions for establishing independent new energy vehicle makers, speeds up merger-and-reorganisation and the reform of grouped qualification management, and extends capacity control to power batteries by requiring stronger early-warning and control management of power-battery capacity.
    “产能预警调控”首次写入行业五年规划:严格新建独立新能源车企条件,兼并重组、资质集团化管理改革提速,并将产能调控触角延伸至动力电池环节,提出加强动力电池产能预警和调控管理。
  • On 29 September 2026 the Department of Science and Technology of the Ministry of Industry and Information Technology published for comment 29 recommended national standard plan projects, including the Technical Requirements and Test Methods for Supply-Chain Cybersecurity of Intelligent Connected Vehicles; the comment period runs from 30 September to 29 October 2026.
    2026 年 9 月 29 日,工业和信息化部科技司公示《智能网联汽车 供应链网络安全技术要求及试验方法》等 29 项推荐性国家标准计划项目,公示时间为 2026 年 9 月 30 日至 2026 年 10 月 29 日。

China’s 15th Five-Year Plan for Intelligent Connected NEVs: Targets, Guardrails and What It Means for Foreign Investors | 中国智能网联新能源汽车”十五五”规划:目标、护栏与外资含义

Overview

The Intelligent Connected New Energy Vehicle Industry “15th Five-Year Plan” was jointly issued by nine departments, led by the Ministry of Industry and Information Technology. The co-issuing bodies are the National Development and Reform Commission, the Ministry of Public Security, the Ministry of Transport, the Ministry of Commerce, the Ministry of Natural Resources, the Ministry of Housing and Urban-Rural Development, the State Administration for Market Regulation and the Cyberspace Administration of China.

The plan sets the sector’s direction to 2030 across three layers: quantified market-share targets, an organising structure of tasks, projects and actions, and a governance layer that for the first time puts capacity early-warning and control into an industry five-year plan. Running alongside it is a standards programme, of which the most immediately relevant piece is a set of 29 recommended national standard plan projects opened for public comment in late September 2026.

The 2030 targets

By 2030, the plan aims for China’s whole-industry-chain advantage in intelligent connected new energy vehicles to be further consolidated, and for the country to join the ranks of the world’s automotive powers. Two quantified targets anchor the market dimension: new energy passenger vehicles are to account for 70% of new-vehicle sales in their respective segments, and commercial vehicles for 40%. On the technology dimension, the plan states that vehicles with autonomous-driving functions are to achieve large-scale application.

Five areas, 17 tasks, four projects, three actions

The plan deploys five areas and 17 key tasks: raising technological innovation capability; promoting the optimisation and upgrading of the industrial system; advancing cross-sector integrated development; building a scientific and efficient industry-governance system; and opening a new chapter in global industrial cooperation.

Four major projects support those tasks: the intelligent connected new energy vehicle key-technology breakthrough project; the standards and testing-evaluation capability improvement project; the intelligent connected new energy vehicle safety foundation project; and the internationalisation capability upgrade project.

Three priority actions translate the projects into workstreams: the “artificial intelligence plus automobile” development action; the key-component ecosystem development and leading-enterprise cultivation action; and the intelligent connected new energy vehicle application-promotion action.

Capacity early-warning and control enter a five-year plan

The governance layer is where the plan breaks new ground. Capacity early-warning and control is written into an industry five-year plan for the first time. In practice this shows up in three ways: the conditions for establishing independent new energy vehicle makers are tightened; merger and reorganisation and the reform of grouped qualification management are accelerated; and the reach of capacity control is extended to power batteries, with the plan calling for stronger early-warning and control management of power-battery capacity.

For a foreign investor weighing a new greenfield vehicle or battery plant, this is the provision that most directly changes the arithmetic: entry conditions, qualification structure and the capacity conversation are all being moved into a more managed framework.

The standards system: six specialised domains

The plan requires the continued development and improvement of specialised standards systems in six domains: automotive chips, automotive software, data governance and applications, automotive artificial intelligence, automotive solid-state batteries and low-carbon automotive development.

It also addresses market conduct: regulating the release of industry data and information and the payment of enterprise accounts; strengthening market-supervision enforcement; reinforcing anti-monopoly, anti-unfair-competition and price enforcement and justice; and intensifying quality supervision and inspection, defect investigation and product-consistency supervision and inspection.

The 29 draft national standards on supply-chain cybersecurity

On 29 September 2026 the Department of Science and Technology of the Ministry of Industry and Information Technology published for public comment 29 recommended national standard plan projects, among them the Technical Requirements and Test Methods for Supply-Chain Cybersecurity of Intelligent Connected Vehicles. The comment period runs from 30 September to 29 October 2026, and comments are submitted online through the “standards project initiation — project initiation publicity” section of the Ministry of Industry and Information Technology Standards Information Service Platform (https://std.miit.gov.cn).

The drafting of a supply-chain cybersecurity standard for intelligent connected vehicles sits directly under the plan’s automotive-software and automotive-artificial-intelligence standard domains. For suppliers, it is the earliest visible signal of the technical requirements that intelligent connected vehicle supply chains will be expected to meet.

Separately, the State Administration for Market Regulation (Standardization Administration of China) approved and released the national standard on automotive software quality and defect management around 14 September 2026, adding a quality-management counterpart to the technical standards workstream.

Global supply chain and foreign investment cooperation

The plan sets out to build a global industrial chain and supply chain, to improve overseas development service capability, and to support foreign-invested enterprises in investing and cooperating in China.

On 28 September 2026, at the press conference for the 2026 World Intelligent Connected Vehicle Conference, Hao Lishun, deputy director of the First Department of Equipment Industry of the Ministry of Industry and Information Technology, answered questions and set out three areas of work. First, making industrial chain and supply chain cooperation closer — including supporting foreign-invested enterprises in deepening their presence in the Chinese market. Second, deepening international coordination of standards and regulations — actively participating in international standards and regulations activities under mechanisms including the United Nations World Forum for Harmonization of Vehicle Regulations (WP.29), the International Organization for Standardization and the International Electrotechnical Commission, and promoting coordination in the development of standards and regulations for autonomous driving and electric vehicles. Third, making enterprises’ international development more stable — improving supporting arrangements such as cross-border logistics and investment and financing, strengthening overseas risk prevention and corporate compliance, and guiding enterprises to carry out overseas deployment in a prudent and orderly manner.

Judicial rules on AI-related disputes

On 7 September 2026 the Supreme People’s Court of China issued its Opinions on Trying Cases Involving Artificial-Intelligence-Related Disputes, which address liability where a vehicle defect and driver fault cause the same damage, and liability for misleading promotion of a vehicle’s automation level, intelligence, performance or use.

Practical notes for foreign investors

  • Read the capacity layer first. The tightening of conditions for new independent NEV makers and the extension of capacity control to batteries are the provisions that shape whether a new plant is approvable.
  • Track the six standard domains. Automotive chips, software, data governance, automotive AI, solid-state batteries and low-carbon development are the areas where technical requirements will be formalised.
  • Follow the 29 draft standards. Supply-chain cybersecurity is the first of the batch to watch, with comments open until 29 October 2026.
  • Use the cooperation channels. The plan and the 28 September briefing both explicitly support foreign-invested enterprises deepening their China presence and participating in international standards work under WP.29, ISO and IEC.

Sources

  • 工业和信息化部(《智能网联新能源汽车产业发展”十五五”规划》通知): https://www.miit.gov.cn/zwgk/zcwj/wjfb/tz/art/2026/art_47e6f99ffbe945279ef3ffd23c5b3631.html
  • 工业和信息化部科技司(29 项推荐性国家标准计划项目立项公示): https://www.miit.gov.cn/jgsj/kjs/jscx/bzgf/art/2026/art_88f891ce12ee49eabf2a3585eca08ee1.html
  • 工业和信息化标准信息服务平台(标准立项—立项公示): https://std.miit.gov.cn
  • 中国工业新闻网(规划与标准相关报道): https://www.cinn.cn/yc/2026/09-29/LkvqQ7aD.html
  • 上海市人民政府外事办公室(政策转载): https://wsb.sh.gov.cn/ztzl/shzxzb/20260923/3a34c2e581c04aa4a3eb7dafedd9e404.html
  • 国家发展改革委(新闻发布会): https://www.ndrc.gov.cn/xwdt/wszb/9yfbh

Related reading

  • see also: 智能网联新能源汽车”十五五”规划解读(341-nev-15th-fyp-plan)
  • see also: 机动车生产一致性监督检查专项行动(378-vehicle-production-consistency-campaign)

中国智能网联新能源汽车”十五五”规划:目标、护栏与外资含义

概述

《智能网联新能源汽车产业发展”十五五”规划》由工业和信息化部会同国家发展改革委、公安部、交通运输部、商务部、自然资源部、住房和城乡建设部、市场监管总局、国家网信办(共九部门)联合印发。

规划以三个层次界定 2030 年前的方向:量化的市场份额目标;由重点任务、重大工程、重点行动构成的推进结构;以及首次把产能预警调控写入行业五年规划的治理层。与之并行的是标准工作,其中与产业主体最直接相关的一项,是 2026 年 9 月下旬公开征求意见的 29 项推荐性国家标准计划项目。

2030 年目标

规划提出,到 2030 年,我国智能网联新能源汽车全产业链优势进一步巩固,进入世界汽车强国行列。市场维度有两个量化目标锚定:国内新能源乘用车在各自领域新车总销量占比达 70%,商用车达 40%。技术维度上,规划提出具备自动驾驶功能的汽车实现规模应用。

5 方面 17 项任务、4 项工程、3 项行动

规划部署 5 方面 17 项重点任务:提高技术创新能力;推动产业体系优化升级;促进跨界融合发展;构建科学高效的行业治理体系;开创全球产业合作新局面。

4 项重大工程为上述任务提供支撑:智能网联新能源汽车关键技术攻关工程;标准及测试评价能力提升工程;智能网联新能源汽车安全筑基工程;国际化能力跃升工程。

3 项重点行动把工程转化为具体工作流:”人工智能+汽车”发展行动;关键零部件生态建设和领军企业培育行动;智能网联新能源汽车应用推广行动。

产能预警调控首次写入五年规划

治理层是规划的突破之处。”产能预警调控”首次写入行业五年规划。具体体现为三条:严格新建独立新能源车企条件;兼并重组、资质集团化管理改革提速;将产能调控触角延伸至动力电池环节,提出加强动力电池产能预警和调控管理。

对正在评估新建整车或电池工厂的外国投资者而言,这一条最直接地改变测算:准入条件、资质结构与产能议题,都被移入一个更强调管理的框架之中。

标准体系:六个专项领域

规划要求持续建立完善六个专项标准体系:汽车芯片、汽车软件、数据治理及应用、汽车人工智能、车用固态电池、汽车低碳发展。

规划同时规范市场行为:规范行业数据信息发布和企业账款支付;加强市场监管执法;强化反垄断、反不正当竞争和价格执法司法;加强质量监督检查、缺陷调查和产品一致性监督检查力度。

供应链网络安全:29 项国家标准立项公示

2026 年 9 月 29 日,工业和信息化部科技司公示《智能网联汽车 供应链网络安全技术要求及试验方法》等 29 项推荐性国家标准计划项目。公示时间为 2026 年 9 月 30 日至 2026 年 10 月 29 日,意见通过”工业和信息化标准信息服务平台”(https://std.miit.gov.cn)”标准立项—立项公示”栏目在线反馈。

智能网联汽车供应链网络安全标准的立项,正落在规划的汽车软件与汽车人工智能两个标准领域之下。对供应商而言,这是智能网联汽车供应链将要满足的技术要求最早可见的信号。

此外,市场监管总局(国家标准委)于 2026 年 9 月 14 日前后批准发布《汽车软件质量与缺陷管理规范》国家标准,为技术标准工作补充了质量管理维度的对应文件。

全球产业链供应链与外资合作

规划提出构建全球产业链供应链、提升海外发展服务能力、支持外资企业在华投资合作等目标任务。

2026 年 9 月 28 日,在 2026 世界智能网联汽车大会新闻发布会上,工业和信息化部装备工业一司副司长郝立顺答记者问,明确工信部将重点做好三方面工作。其一,推动产业链供应链合作更加紧密,包括支持外资企业深耕中国市场。其二,推动标准法规国际协同更加深入,积极参与联合国世界车辆法规协调组织(WP.29)、国际标准化组织、国际电工委员会等机制下的国际标准法规活动,推动自动驾驶、电动汽车等标准法规制定协调。其三,推动企业国际化发展更加稳健,完善跨境物流、投融资等配套支撑,加强海外风险防范和企业合规建设,引导企业稳妥有序开展海外布局。

涉人工智能纠纷案件的司法规则

2026 年 9 月 7 日,中国最高人民法院发布《关于依法审理涉人工智能纠纷案件的意见》,对车辆缺陷与驾驶人过错行为结合致损的责任,以及对车辆自动化等级、智能程度、性能、用途等作虚假或者引人误解宣传的责任作出规定。

外资企业实务提示

  • 先读产能层。 严格新建独立新能源车企条件,以及产能调控向电池环节延伸,是决定新建工厂能否获批的条款。
  • 跟踪六个标准领域。 汽车芯片、汽车软件、数据治理、汽车人工智能、车用固态电池与汽车低碳发展,是技术要求将被正式化的方向。
  • 关注 29 项立项公示。 供应链网络安全是本批中最值得跟踪的一项,意见反馈开放至 2026 年 10 月 29 日。
  • 用好合作通道。 规划与 9 月 28 日发布会均明确支持外资企业深耕中国市场,并参与 WP.29、ISO、IEC 机制下的国际标准工作。

来源

  • 工业和信息化部(《智能网联新能源汽车产业发展”十五五”规划》通知): https://www.miit.gov.cn/zwgk/zcwj/wjfb/tz/art/2026/art_47e6f99ffbe945279ef3ffd23c5b3631.html
  • 工业和信息化部科技司(29 项推荐性国家标准计划项目立项公示): https://www.miit.gov.cn/jgsj/kjs/jscx/bzgf/art/2026/art_88f891ce12ee49eabf2a3585eca08ee1.html
  • 工业和信息化标准信息服务平台(标准立项—立项公示): https://std.miit.gov.cn
  • 中国工业新闻网(规划与标准相关报道): https://www.cinn.cn/yc/2026/09-29/LkvqQ7aD.html
  • 上海市人民政府外事办公室(政策转载): https://wsb.sh.gov.cn/ztzl/shzxzb/20260923/3a34c2e581c04aa4a3eb7dafedd9e404.html
  • 国家发展改革委(新闻发布会): https://www.ndrc.gov.cn/xwdt/wszb/9yfbh

相关阅读

  • 见:智能网联新能源汽车”十五五”规划解读(341-nev-15th-fyp-plan)
  • 见:机动车生产一致性监督检查专项行动(378-vehicle-production-consistency-campaign)

China’s Foreign Investment Negative List in 2026: Sector Opening, Encouraged Catalogue and Market Access in Practice

  • China’s national foreign-investment negative list stands at 29 items and the free-trade-zone version at 27 items, with all manufacturing access restrictions eliminated — including the removal of the “publication printing must be Chinese-controlled” and “prohibition on Chinese medicine decoction-piece processing technology” limits.
    全国版外资准入负面清单为 29 条,自由贸易试验区版为 27 条,制造业领域外资准入限制措施已全部清零——包括取消”出版物印刷须由中方控股”与”禁止投资中药饮片炮制技术”等限制。
  • The 15th Five-Year Plan commits to expanding market access with services as the focus, promoting the orderly opening of telecom, internet, education, culture and healthcare, and piloting value-added telecom, biotechnology and wholly foreign-owned hospital regimes.
    “十五五”规划纲要以服务业为重点扩大市场准入,推动电信、互联网、教育、文化、医疗等领域有序扩大开放,稳妥实施增值电信、生物技术、外商独资医院等开放试点。
  • At the September 2026 NDRC roundtable with multinational firms, authorities signalled continued services opening, higher investment convenience, optimised cross-border data flows, the profit-reinvestment tax preference, and a push to make foreign firms both “admitted and operable” by clearing inconsistent local rules and unblocking post-access bottlenecks.
    在 2026 年 9 月国家发展改革委与跨国企业高层圆桌会上,主管部门释放持续扩大服务业开放、提升投资便利度、优化数据跨境流动、落实利润再投资税收优惠,并通过清理不符文件、打通准营堵点落实外资企业”准入又准营”的信号。
  • The negative list answers “can you enter”; the Catalogue of Encouraged Industries (2025 edition, NDRC and MOFCOM Order No. 37, effective 1 February 2026) answers “what support you get once in” — the two instruments are applied in combination, not in isolation.
    负面清单管”能不能进”,《鼓励外商投资产业目录(2025 年版)》(国家发展改革委、商务部第 37 号令,2026 年 2 月 1 日施行)管”进了有什么支持”,二者叠加使用而非各自孤立。
  • The binding constraint is shifting from access to operation permission: sector licences, product registration, government procurement and standards participation now do much of the screening, so pre-investment screening must pair the list check with a catalogue and a post-access bottleneck map.
    约束重心正从准入转向准营:行业许可、产品注册、政府采购与标准参与承担了大部分筛选,故投资前筛查须将清单核查与鼓励目录、准营堵点地图并列推进。
  • Practical steps: screen the business scope against the current list and the FTZ list, use standardised business-scope wording, distinguish filing from approval, and pre-empt post-access blockages in licensing, procurement and standards.
    实操步骤:将经营范围对照现行全国与自贸试验区清单,使用规范经营范围表述,区分备案制与核准制,并预先应对许可、政府采购、标准制定等准营堵点。

China’s Foreign Investment Negative List in 2026: Sector Opening, Encouraged Catalogue and Market Access in Practice | 2026 年中国外资准入负面清单:行业开放、鼓励目录与准入实操

Overview

The foreign-investment negative list is the gateway instrument of China’s market-access system: outside the listed items, foreign investors are treated on a par with domestic ones under the pre-establishment national-treatment-plus-negative-list regime. In 2026 the list is stable in length but active in meaning — 29 national items, 27 in the free-trade zones, manufacturing fully cleared — with the year’s policy energy directed at services and at the post-access journey where licences and standards do the screening. This article maps the list landscape, the 15th Five-Year Plan, the September 2026 NDRC roundtable signals, and how the list interacts with the Catalogue of Encouraged Industries (2025 edition), then sets out a screening method and common post-access bottlenecks.

The current negative-list landscape

The operative national negative list is the 2024 edition (NDRC and MOFCOM Order No. 23), in force since 1 November 2024, with 29 items — the shortest in the instrument’s history. Through 2026 no new national edition has been published. The free-trade-zone negative list stands at 27 items. Manufacturing access restrictions have been fully “zeroed out”: compared with the 2021 edition, the 2024 national list deleted the last two manufacturing limits — “publication printing must be Chinese-controlled” and “prohibition on investment in the application of Chinese medicine decoction-piece processing techniques such as steaming, frying, roasting and calcining, and in the production of products with confidential traditional Chinese medicine prescriptions” — leaving manufacturing without foreign-access restrictions.

What remains concentrates on a narrow set of security- and sensitivity-related sectors: news and publishing, culture, education, telecom, mining and agricultural breeding. Strategically, the list is now a stable floor; the next movement is expected in services, via pilots and mechanism-building rather than a single full revision.

The 15th Five-Year Plan deployment

The 15th Five-Year Plan outline frames the opening agenda. It commits to expanding market access with services as the priority and opening more fields, attracting foreign investment. It names telecom, internet, education, culture and healthcare as the sectors for orderly further opening, and it tasks the authorities with piloting value-added telecom, biotechnology and wholly foreign-owned hospital regimes, while advancing comprehensive pilots and demonstrations of services-sector opening. The plan’s logic is that, with manufacturing largely open, the marginal liberalisation that matters to foreign investors sits in services and in the operating environment after entry.

The September 2026 NDRC roundtable: the post-access signal

On 10–11 September 2026, the NDRC held a high-level roundtable with multinational firms in Beijing under the theme of embracing the 15th Five-Year Plan. The signals most relevant to market access were concrete and forward-looking.

On opening: officials stated that during the 15th Five-Year Plan period, on the basis of fully assessing existing pilots, China will continue to promote the orderly opening of telecom, internet, education, culture and healthcare, and prudently implement pilots in value-added telecom, biotechnology and wholly foreign-owned hospitals; it will steadily expand financial-market connectivity, optimise the qualified foreign-investor regime and broaden investable products, and orderly advance eligible enterprises’ cross-border two-way direct financing.

On the business environment: officials pledged to further raise the convenience of foreign investment, optimise cross-border data-flow management, and implement the tax preference for overseas investors’ direct investment with distributed profits. On the core post-access agenda, the NDRC’s foreign-investment department stated that a key task is to deliver foreign firms being “both admitted and operable” — supervising local governments to continuously clear documents and rules inconsistent with the Foreign Investment Law, unblocking the bottlenecks that foreign firms hit after admission, and prudently advancing value-added-telecom, biotechnology and foreign-invested-hospital pilots in relevant localities. It also committed to introducing optimisation measures and fully implementing national treatment for foreign firms.

The takeaway for investors is that the 2026 agenda is less about shrinking the list’s item count and more about making the remaining items operable, and about removing the local rules and licensing frictions that sit behind the list.

Negative list meets encouraged catalogue: a combined method

The negative list and the Catalogue of Encouraged Industries answer different questions. The negative list sets the ceiling — what is prohibited or capped. The Catalogue of Encouraged Industries (2025 edition, NDRC and MOFCOM Order No. 37, effective 1 February 2026) sets the floor of support — what is encouraged and what benefits follow. The 2025 catalogue has 1,679 entries in total: a national catalogue of 619 entries and a regional catalogue of 1,060 entries for central-west, northeast and Hainan, guiding foreign investment into advanced manufacturing, modern services, high-tech, energy conservation and environmental protection, and into central-west and northeast regions.

The method applies the two in combination. Step one: confirm the target sector is not on the negative list (or, if capped, design a compliant ownership structure). Step two: check whether the sector or a sub-item appears in the encouraged catalogue — if so, the project may qualify for import, land and tax support at national and local levels. Step three: note that encouragement does not override the list — a sector can be both encouraged and, in a specific sub-activity, still restricted, so the two must be read together. The Action Plan for Stabilising and Optimizing Foreign Investment (Shangzi Fa [2026] No. 97) is the operational bridge: it opens services pilots and steers support to encouraged activities, so the list, the catalogue and the action plan should be consulted together.

Pre-investment screening in practice

  1. Screen the business scope against the list. Map the proposed activity to the 29-item national list and, if entering a pilot zone, to the 27-item FTZ list; confirm whether the activity is prohibited, capped (e.g., equity ratio) or free.
  2. Use standardised business-scope wording. Register the business scope with the standardised expressions from the national business-scope registration system; vague or non-standard wording is a frequent cause of downstream licensing friction.
  3. Distinguish filing from approval. Most post-access items are record-filing (备案); a smaller set requires administrative approval (核准) or a sector licence. Identify which applies before committing capital, because approval items carry a harder gate than filing.
  4. Read the encouraged catalogue in parallel. Check the national and regional catalogues for the sector; if present, build the incentive case (imports, land, tax) into the investment model from day one.
  5. Draw a post-access bottleneck map. List the licences, product registrations, procurement qualifications and standards bodies the venture will need, and assess each as a gate before signing.

Common post-access bottlenecks and responses

The “admitted but not operable” problem recurs in three places. First, licensing: a cleared entry still needs the sector licence (medical, telecom or education), with its own timetable — start it with incorporation. Second, government procurement and subsidies: eligibility often turns on domestic standards, local presence and compliance records; assemble evidence early. Third, standards: the ability to sell may depend on conformity with mandatory and recommended standards and on a voice in standard-setting; track the technical committees and conformity pathways.

Treat the negative list as the first checkbox, not the last. Pair it with the encouraged catalogue for support and with a candid post-access map for execution.

Sources

  • 中国政府网《中国”十五五”规划,为世界提供新机遇》: https://www.gov.cn/yaowen/liebiao/202609/content_7081427.htm
  • 中国政府网 政策解读《2024 年版全国外资准入负面清单发布 制造业领域外资准入限制措施”清零”》(29 条、制造业清零、出版物印刷与中药饮片条目取消): https://www.gov.cn/zhengce/202409/content_6973149.htm
  • 国家发展改革委 答记者问《外商投资准入特别管理措施(负面清单)(2024 年版)》(全国版 29 条、自贸试验区版 27 条、制造业清零): https://www.ndrc.gov.cn/xxgk/jd/jd/202409/t20240907_1392877.html
  • 国家发展改革委《鼓励外商投资产业目录(2025 年版)》解读(第 37 号令,2026 年 2 月 1 日施行,总条目 1679 条): https://www.ndrc.gov.cn/xxgk/jd/jd/202512/t20251224_1402574.html
  • 中国新闻网《苹果、霍尼韦尔、康宁等在华美企面对面提问国家发改委》(2026 年 9 月圆桌会、”准入又准营”、清理不符文件、打通准营堵点): https://www.chinanews.com.cn/cj/2026/09-10/10694229.shtml
  • 商务部《利用外资固稳促优行动方案》(商资发〔2026〕97 号): https://www.mofcom.gov.cn/zcfb/wgtzgl/art/2026/art_0cfe31a63f9c4bd3869517bc10908c10.html
  • 国家发展改革委: https://www.ndrc.gov.cn/
  • 商务部: https://www.mofcom.gov.cn/

2026 年中国外资准入负面清单:行业开放、鼓励目录与准入实操

概述

外资准入负面清单是中国市场准入体系的闸口工具:清单之外,外国投资者在准入前国民待遇加负面清单管理体制下与内资一视同仁。2026 年清单篇幅稳定但意涵活跃——全国版 29 条、自贸试验区版 27 条、制造业限制全部清零,政策能量投向”准入到准营”这段由行业许可与标准承担实质筛选的旅程。本文勾勒现行清单格局、”十五五”部署、2026 年 9 月发改委圆桌会信号,并说明负面清单如何与《鼓励外商投资产业目录(2025 年版)》衔接,最后给出投资前筛查方法与常见准营堵点。

现行负面清单格局

现行有效的全国版清单是 2024 年版(国家发展改革委、商务部第 23 号令),自 2024 年 11 月 1 日起施行,共 29 条——为制度设立以来最短版本。2026 年全年尚未发布新版全国清单。自由贸易试验区版清单为 27 条。制造业准入限制已全面”清零”:相比 2021 年版,2024 年全国版删除了制造业仅剩的两条限制——”出版物印刷须由中方控股”与”禁止投资中药饮片的蒸、炒、炙、煅等炮制技术的应用及中成药保密处方产品的生产”——制造业已无外资准入限制。

清单剩余条目集中于少数安全与敏感领域:新闻出版、文化、教育、电信、采矿、农业育种等。战略上清单已成”稳定的地板”,下一步动作预计出现在服务业,通过试点与机制建设推进,而非一次全盘修订。

“十五五”规划部署

“十五五”规划纲要框定了开放议程。它以服务业为重点扩大市场准入、拓展开放领域,吸引外资;点名电信、互联网、教育、文化、医疗为有序扩大开放的领域,并部署稳妥实施增值电信、生物技术、外商独资医院等开放试点,推进服务业扩大开放综合试点示范。其逻辑是:制造业基本放开后,对外国投资者真正重要的边际开放落在服务业与进入后的经营环境。

2026 年 9 月发改委圆桌会:准营端信号

2026 年 9 月 10 日至 11 日,国家发展改革委以”拥抱’十五五'”为主题在北京召开与跨国企业高层圆桌会。与准入最相关的信号具体且前瞻。

开放方面:有关负责人表示,”十五五”时期将在充分评估现有试点基础上,持续推动电信、互联网、教育、文化、医疗等领域有序扩大开放,稳妥实施增值电信、生物技术、外商独资医院等开放试点;稳慎拓展金融市场互联互通,优化合格境外投资者制度、扩大可投资品种范围,有序推进符合条件的企业跨境双向直接融资。

营商环境方面:将进一步提升外商投资便利度、优化数据跨境流动管理、落实境外投资者以分配利润直接投资税收优惠政策。在准营核心议程上,国家发展改革委外资司表示,外资领域一项重点工作就是落实好外资企业”准入又准营”——督导各地持续清理与外商投资法不符的文件法规,打通外资企业准营的堵点卡点,同时稳妥推动有关地方开展增值电信、生物技术、外商投资医院等试点,并推动出台优化措施、全面落实外资企业国民待遇。

对投资者的要义是:2026 年议程的重点不在于压缩清单条数,而在于让剩余条目”可运营”,并清除清单背后的地方文件与许可摩擦。

负面清单衔接鼓励目录:叠加方法

负面清单与鼓励目录回答不同问题。负面清单设定上限——什么禁止或受限;鼓励目录(2025 年版,国家发展改革委、商务部第 37 号令,2026 年 2 月 1 日施行)设定支持的底线——什么受鼓励、进入后享有什么利好。2025 年版鼓励目录共 1679 条:全国目录 619 条,中西部等地区外商投资优势产业目录 1060 条,引导外资投向先进制造业、现代服务业、高新技术、节能环保及中西部、东北地区。

方法是二者叠加使用。第一步:确认目标行业不在负面清单上(若受限,则设计合规的股权结构)。第二步:核查该行业或其具体条目是否出现在鼓励目录——若在,项目可适用进口、用地、税收等支持政策。第三步:注意鼓励不凌驾于限制,某一行业可同时”受鼓励”又在某项具体活动上”仍受限”,故二者须对照阅读,不能假定互斥。《利用外资固稳促优行动方案》(商务部、国家发展改革委、财政部印发,商资发〔2026〕97 号,经国务院同意)是操作桥梁:既开放服务业试点,又将支持导向鼓励类活动,故清单、目录与行动方案应一并查阅。

投资前筛查实操

  1. 对照清单筛查经营范围。将拟议活动映射到 29 条全国版清单;进入试点区域的,再对照 27 条自贸试验区版;确认属于禁止、受限(如股比)或自由。
  2. 使用规范经营范围表述。通过全国统一经营范围规范表述系统登记经营范围;表述模糊或非标准,是下游许可摩擦的常见诱因。
  3. 区分备案制与核准制。多数准营事项为备案;少数须行政审批或行业许可。注资前识别适用类别,因核准事项门槛硬于备案。
  4. 并行查阅鼓励目录。核查全国与地区目录是否含该行业;若含,自第一天起将进口、用地、税收等激励纳入投资模型。
  5. 绘制准营堵点地图。列出企业将需要的许可、产品注册、采购资质与标准机构,在签约前将每一项评估为关卡。

常见准营堵点与应对

“准入不准营”集中出现在三处。其一,许可:清单已放行的项目仍需行业许可(如医疗、电信、教育牌照),且许可申请自有时间表与实质要求——应与设立并行启动。其二,政府采购与补贴:资格常取决于是否符合国内标准、本地存在与合规记录,尽早备齐证据包。其三,标准参与:能否销售可能取决于是否符合强制性与推荐性标准、能否参与标准制定,跟踪相关技术委员会与合格评定路径。

建设性姿态是把负面清单当作第一个勾选项而非最后一个,与鼓励目录搭配获支持、与准营地图搭配落地执行。2026 年 9 月信号表明,通过外资企业圆桌会与一站式窗口提出准营堵点问题,是被认可的渠道。

来源

  • 中国政府网《中国”十五五”规划,为世界提供新机遇》:https://www.gov.cn/yaowen/liebiao/202609/content_7081427.htm
  • 中国政府网 政策解读《2024 年版全国外资准入负面清单发布 制造业领域外资准入限制措施”清零”》(29 条、制造业清零、出版物印刷与中药饮片条目取消):https://www.gov.cn/zhengce/202409/content_6973149.htm
  • 国家发展改革委 答记者问《外商投资准入特别管理措施(负面清单)(2024 年版)》(全国版 29 条、自贸试验区版 27 条、制造业清零):https://www.ndrc.gov.cn/xxgk/jd/jd/202409/t20240907_1392877.html
  • 国家发展改革委《鼓励外商投资产业目录(2025 年版)》解读(第 37 号令,2026 年 2 月 1 日施行,总条目 1679 条):https://www.ndrc.gov.cn/xxgk/jd/jd/202512/t20251224_1402574.html
  • 中国新闻网《苹果、霍尼韦尔、康宁等在华美企面对面提问国家发改委》(2026 年 9 月圆桌会、”准入又准营”、清理不符文件、打通准营堵点):https://www.chinanews.com.cn/cj/2026/09-10/10694229.shtml
  • 商务部《利用外资固稳促优行动方案》(商资发〔2026〕97 号):https://www.mofcom.gov.cn/zcfb/wgtzgl/art/2026/art_0cfe31a63f9c4bd3869517bc10908c10.html
  • 国家发展改革委:https://www.ndrc.gov.cn/
  • 商务部:https://www.mofcom.gov.cn/

Pharma and biotech opening moves from the foreign-investment action plan: segmented production, pilot expansion and the payment chain

  • The Action Plan for Stabilising and Optimising the Utilisation of Foreign Investment (商资发〔2026〕97号, issued 16 June 2026 by MOFCOM, NDRC and MOF) commits the government to “expedite the study and issuance of implementation rules for segmented pharmaceutical production”, easing cross-border segmented manufacturing of biologics and chemical drugs by foreign marketing-authorisation holders.
    商务部、国家发展改革委、财政部《利用外资固稳促优行动方案》(商资发〔2026〕97号,2026年6月16日印发)明确”抓紧研究出台药品分段生产实施细则”,便利境外药品上市许可持有人开展生物制品、化学药品跨境分段生产。
  • The same plan moves to widen pilot geography: authorities will “expedite research and approval to further expand the pilot regions for biotechnology and wholly foreign-owned hospitals” — the two most-watched restricted-service openings of the current cycle.
    同一方案还推动试点扩围:”抓紧研究报批进一步扩大生物技术、外商独资医院领域开放试点区域范围”——这是本轮最受关注的两项限制性服务业开放。
  • The statutory base is already in place: the revised Drug Administration Law Implementation Regulations (published January 2026) turned segmented production from pilot into institution, letting marketing-authorisation holders commission qualified producers to segment-manufacture innovative drugs and clinically urgent drugs when genuinely needed, under a unified quality-assurance system covering all sites.
    法定底座已经就位:修订后的《药品管理法实施条例》(2026年1月公布)把分段生产从试点推向制度——药品上市许可持有人确有需要的,可委托符合条件的企业分段生产创新药、临床急需药品等,并建立覆盖全部生产场地的统一质量保证体系。
  • Commercial proof-of-concept has landed: in May 2026 Johnson & Johnson’s niccalimab injection became the first imported biologic to run domestic segmented production of drug substance in China, with the substance made by WuXi Bio in Wuxi and fill-finish completed in Germany.
    商业验证已经落地:2026年5月,强生制药的尼卡利单抗注射液成为全国首个开展原液境内分段生产的进口生物制品——原液由无锡药明生物生产,制剂在德国完成。
  • Biotech opening pilots are producing registrable outcomes: under the 2024 pilot allowing FIEs to develop and apply human stem-cell and gene diagnosis and therapy technologies in designated free trade zones, at least six foreign companies — including Merck, JW Therapeutics-related entities, Frontera Therapeutics and StarCellBio — have completed registration changes or new filings.
    生物技术开放试点已产出可登记成果:在2024年允许外商投资企业于指定自贸区开展人体干细胞、基因诊断与治疗技术开发应用的试点下,至少6家外资企业(含默克、药明巨诺相关主体、芳拓生物、星奕昂等)已完成经营范围变更或新设登记。
  • Payment and channel measures complete the chain: the plan supports insurers in covering more innovative drugs and devices under commercial health insurance, and calls for an industry collaboration platform to smooth foreign-made pharmaceuticals into retail channels — the “last mile” that has capped foreign pharma revenue in China.
    支付与渠道措施补齐链条:方案支持保险公司将更多创新药械纳入商业保险保障范围,并搭建行业协作平台便利外资企业生产的药品进入零售渠道——这正是此前封顶外资药企中国收入的”最后一公里”。

Pharma and biotech opening moves from the foreign-investment action plan: segmented production, pilot expansion and the payment chain | 外资行动方案中的医药开放组合:分段生产、试点扩围与支付渠道

Overview

The Action Plan for Stabilising and Optimising the Utilisation of Foreign Investment (《利用外资固稳促优行动方案》, 商资发〔2026〕97号), issued on 16 June 2026 by the Ministry of Commerce, the National Development and Reform Commission and the Ministry of Finance with State Council consent, devotes one of its fifteen measures to pharmaceuticals. The measure assembles a “production — marketing-authorisation — payment — channel” package for foreign pharmaceutical and biotech companies: segmented production implementation rules, expanded pilot geography for biotechnology and wholly foreign-owned hospitals, commercial-insurance payment support, and retail-channel facilitation.

With September 2026 commentary from the Shanghai government’s weekly foreign-invested information service now tracking the package in detail, the measures are the clearest single statement of where foreign pharma market access in China is heading this cycle.

Segmented production: from pilot to statute to rules

Segmented production (分段生产) distributes a drug’s manufacturing process across sites or companies — globally common, but long restricted in China. The progression:

  • October 2024: the National Medical Products Administration issued the pilot work plan for segmented production of biologics, allowing certain innovative and clinically urgent biologics to run segmented production at the pilot stage.
  • January 2026: the State Council published the revised Drug Administration Law Implementation Regulations, moving segmented production into institution. Article 31 provides that where a marketing-authorisation holder genuinely needs it, the holder may commission qualified manufacturers to segment-manufacture (i) innovative drugs with special process, facility or equipment requirements, (ii) clinically urgent drugs and drugs needed for public-health response or reserves identified by the State Council departments, and (iii) other drugs specified by the drug regulator. The holder must build a unified quality-assurance system covering the whole production process and all sites; vaccines and blood products carry their own commissioning rules.
  • Next step: the action plan’s commitment to issue implementation rules for segmented pharmaceutical production — the operational layer for application conditions, quality-responsibility allocation and regulatory coordination.

The commercial template already exists: in May 2026, Johnson & Johnson’s niccalimab injection became the first imported biologic to run domestic segmented production of drug substance — substance produced by WuXi Biologics in Wuxi, fill-finish completed by Vetter Pharma in Germany. For multinationals, the case demonstrates the operating model the rules will generalise: foreign marketing-authorisation holders placing upstream segments with qualified Chinese CDMOs while keeping downstream finishing abroad, or the reverse.

Biotechnology and wholly foreign-owned hospitals: pilot expansion pending approval

Biotechnology (human stem cells, gene diagnosis and therapy) has been open to FIEs only inside designated pilot areas since September 2024, when Beijing, Shanghai and Guangdong free trade zones and Hainan were authorised. The registry shows results: at least six foreign companies — including Merck, entities associated with JW Therapeutics (药明巨诺), Frontera Therapeutics (芳拓生物) and StarCellBio (星奕昂) — have completed business-scope changes or new registrations inside the pilot areas.

The action plan instructs authorities to expedite research and approval for expanding the pilot regions for both biotechnology and wholly foreign-owned hospitals — the same two openings that Shanghai’s 15th Five-Year plan and other provincial documents name as landing priorities. Neither expansion has been formally approved yet; the plan converts the expansion from discussion item into an official workstream with a deadline pressure attached.

Payment and channels: the last-mile package

Two measures address the revenue side that has historically capped foreign pharma’s China performance:

  • Commercial insurance. The plan supports insurers in bringing more innovative drugs and devices into commercial health-insurance coverage — the payer channel that has grown fastest as national reimbursement negotiations compress prices.
  • Retail channels. An industry collaboration platform will be built to facilitate foreign-produced pharmaceuticals entering drug retail channels — addressing the distribution friction that has kept foreign-manufactured drugs out of pharmacy chains even after approval.

What this means for foreign pharma and healthcare groups

  • Map your product portfolio against segmented-production eligibility. The statutory categories are innovative drugs with special process/equipment requirements and clinically urgent or reserve drugs; groups with biologics or special-technology chemicals should identify candidates and pre-qualify Chinese CDMO partners under a unified quality system.
  • Watch the implementation rules, not just the plan. Application conditions, quality-responsibility division and regulatory coordination sit in the forthcoming rules; the drafting is the moment to submit practical comments.
  • Treat pilot expansion as a siting decision. If the biotech and wholly-owned-hospital pilots extend to new provinces, entity location inside a pilot area becomes a structuring variable; hold new China healthcare investments until the expanded map is published.
  • Build the commercial-insurance and retail strategy now. Payment support and retail-channel facilitation are revenue-side measures; groups that prepare health-insurance dossiers and pharmacy distribution agreements can move when the platforms land.
  • Benchmark against the niccalimab case. The first segmented-production precedent defines the documentation and quality-system expectations regulators will apply to the next applications.

Sources

  • 济源产城融合示范区管理委员会(转载)— 商务部 国家发展改革委 财政部关于印发《利用外资固稳促优行动方案》的通知(商资发〔2026〕97号,2026年6月16日,政府官网全文): https://zt.www.jiyuan.gov.cn/zsyz/wstz_zsyz/zcfb/t1008712.html
  • 上海市人民政府外事办公室 — 《上海资讯周报》涉外资讯一站式服务(2026年9月第1期,总第157期,2026年9月2日,医药开放组合与分段生产制度演进综述): https://wsb.sh.gov.cn/ztzl/shzxzb/20260902/d2eb54ce238e4d6d9f5bcac6e428f6e6.html
  • 蒙城县人民政府(转载)— 中华人民共和国药品管理法实施条例(2026年修订版分段生产条款第31—33条全文): https://www.mengcheng.gov.cn/XxgkContent/show/3008349.html

Related reading

  • see also: segmented pharma production pilot mechanics (segmented-pharma-production)
  • see also: wholly foreign-owned hospital pilot requirements (foreign-owned-hospital-pilot)

外资行动方案中的医药开放组合:分段生产、试点扩围与支付渠道

概述

《利用外资固稳促优行动方案》(商资发〔2026〕97号)由商务部、国家发展改革委、财政部经国务院同意于2026年6月16日印发,其十五条举措中专设一条指向医药。该条为外资医药与生物技术企业组装了一套”生产—上市许可—支付—渠道”组合:分段生产实施细则、生物技术与外商独资医院试点扩围、商业保险支付支持与零售渠道便利。

随着2026年9月上海市政府涉外资讯周报对该政策包作出详细追踪解读,这是本周期内中国外资药品准入走向最清晰的一份单项表述。

分段生产:从试点到法定再到细则

分段生产(分段生产)把药品生产过程分布在不同场地或企业之间——全球通行,但在中国长期受限。演进脉络:

  • 2024年10月: 国家药监局印发生物制品分段生产试点工作方案,允许部分创新生物制品和临床急需生物制品在试点阶段开展分段生产。
  • 2026年1月: 国务院公布修订后的《药品管理法实施条例》,把分段生产推向制度。第三十一条规定,药品上市许可持有人确有需要的,可以委托符合条件的药品生产企业分段生产:(一)生产工艺、设施设备有特殊要求的创新药;(二)临床急需药品、应对突发公共卫生事件急需或储备需要的药品;(三)国务院药品监督管理部门规定的其他药品。持有人须建立覆盖药品生产全过程和全部生产场地的统一质量保证体系;疫苗、血液制品另有委托生产规则。
  • 下一步: 行动方案承诺出台药品分段生产实施细则——即申请条件、质量责任划分与监管协调的操作层。

商业模板已经出现:2026年5月,强生制药的尼卡利单抗注射液成为全国首个开展原液境内分段生产的进口生物制品——原液由无锡药明生物生产,制剂由德国Vetter Pharma完成。对跨国药企而言,该案例演示了细则将要推广的运营模式:境外持有人把上游环节放在中国合格CDMO、下游制剂留在境外,或反向操作。

生物技术与外商独资医院:扩围报批中

自2024年9月北京、上海、广东自贸区和海南获准试点以来,生物技术(人体干细胞、基因诊断与治疗)仅对试点区域内FIE开放。登记情况已有产出:至少6家外资企业——包括默克、药明巨诺相关主体、芳拓生物(Frontera Therapeutics)、星奕昂等——已在试点区域内完成经营范围变更或新设登记。

行动方案要求抓紧研究报批进一步扩大生物技术、外商独资医院领域开放试点区域范围——上海”十五五”规划等省级文件点名的同样是这两项开放。扩围尚未正式获批;方案把扩围从讨论事项转为带时限压力的正式工作流程。

支付与渠道:最后一公里

两项措施指向历史上封顶外资药企中国收入的收入端:

  • 商业保险。 方案支持保险公司将更多创新药械纳入商业健康保险保障范围——在国家谈判压缩价格背景下增长最快的支付通道。
  • 零售渠道。 将搭建行业协作平台,便利外资企业生产的药品进入药品零售渠道——解决获批外资药品难以进入连锁药店的流通摩擦。

对外资医药与医疗集团的启示

  • 对照分段生产法定情形梳理产品组合。 法定类别是工艺设施有特殊要求的创新药与临床急需、储备药品;拥有生物制品或特殊工艺化学药的企业应识别候选产品,并按统一质量体系预审中国CDMO伙伴。
  • 盯细则而不止于方案。 申请条件、质量责任划分与监管协调都在即将出台的实施细则中;起草阶段是提交实务意见的窗口。
  • 把试点扩围当作选址变量。 若生物技术与独资医院试点扩展至新省份,主体落位在试点区域内就成为架构变量;新医疗投资可等扩围地图公布后再定。
  • 现在就建商保与零售策略。 支付支持与渠道便利是收入端措施;提前准备健康险材料与药店分销协议的集团,可在平台落地时立即行动。
  • 对标尼卡利单抗案例。 首个分段生产先例界定了监管对后续申请的单证与质量体系预期。

来源

  • 济源产城融合示范区管理委员会(转载)— 《利用外资固稳促优行动方案》通知全文(商资发〔2026〕97号): https://zt.www.jiyuan.gov.cn/zsyz/wstz_zsyz/zcfb/t1008712.html
  • 上海市人民政府外事办公室 — 《上海资讯周报》涉外资讯一站式服务(2026年9月第1期): https://wsb.sh.gov.cn/ztzl/shzxzb/20260902/d2eb54ce238e4d6d9f5bcac6e428f6e6.html
  • 蒙城县人民政府(转载)— 中华人民共和国药品管理法实施条例(分段生产条款全文): https://www.mengcheng.gov.cn/XxgkContent/show/3008349.html

相关阅读

  • 见:药品分段生产试点机制要点(segmented-pharma-production)
  • 见:外商独资医院试点要求(foreign-owned-hospital-pilot)

Services Take Centre Stage: China’s Market-Access Opening as of Late August 2026

  • At a State Council Information Office press conference on 28 August 2026, the Ministry of Commerce confirmed that services are now the centrepiece of market-access opening, with work under way to steadily and prudently expand market access and opening fields with services as the focus.
    在 2026 年 8 月 28 日国新办新闻发布会上,商务部确认服务业已成为市场准入开放的重心,正稳妥有序推动以服务业为重点扩大市场准入和开放领域。
  • The MOFCOM is building National Service Trade Innovation and Development Demonstration Zones in 17 regions (the overall plan was issued in April 2026), positioning them as comprehensive reform-and-opening platforms for services trade in the 15th Five-Year period.
    商务部正在北京等 17 个地区建设国家服务贸易创新发展示范区(总体方案 2026 年 4 月印发),将其定位为”十五五”时期服务贸易综合改革开放平台。
  • The demonstration zones will explore a more open institutional environment for the cross-border movement of funds, people, technology and data, steadily expand services market opening, simplify licensing approval procedures and improve risk-prevention mechanisms.
    示范区将探索优化资金、人员、技术、数据等要素跨境流动的制度环境,稳步有序扩大服务市场开放,简化有关许可审批程序,完善风险防控机制。
  • The cross-border services-trade negative list will be improved to remove barriers to cross-border services trade, and the factor flows closely linked to services trade — people, capital and data — will be made more convenient and secure.
    将完善跨境服务贸易负面清单管理制度,破除跨境服务贸易壁垒,推动与服务贸易密切相关的人员、资金、数据等要素便利、安全地跨境流动。
  • Regional positioning is differentiated: Shanghai will lift its full-chain transport-services capacity, Guangzhou will leverage the Greater Bay Area core-engine role in finance and foreign-related law, and Chengdu will build biomedicine innovation chains and digital-content export clusters.
    各地定位差异化:上海提升全链条运输服务能级,广州发挥大湾区核心引擎功能创新发展金融、涉外法律等服务,成都着力打造生物医药创新链、数字文创出口集群。
  • For foreign service providers, the practical takeaway is a widening, more predictable entry landscape: services sectors are the frontier of liberalisation, demonstration zones offer pilot ground for new licences, and the services negative list defines the boundary.
    对外资服务提供商,实操启示是:准入图景更宽、更可预期——服务业是开放的先行领域,示范区为新牌照提供试验场,跨境服务贸易负面清单划定边界。

Services Take Centre Stage: China’s Market-Access Opening as of Late August 2026 | 服务业站上 C 位:2026 年 8 月底的市场准入开放图景

The 28 August press conference

On 28 August 2026, the State Council Information Office held a press conference on the development of China’s services trade and the preparation of the 2026 China International Fair for Trade in Services (CIFTIS). The MOFCOM officials used the platform to set out the services-focused opening agenda. Vice Minister Yan Dong said that in the 15th Five-Year period, as global industrial chains reconfigure and digital and green transformation accelerates, the MOFCOM will implement a services quality-and-capacity upgrading action, speed up innovation in services trade, and — the key phrase — “steadily and prudently promote the expansion of market access and opening fields with services as the focus”. He also committed to improving the cross-border services-trade negative-list system, removing barriers to cross-border services trade, and making the factor flows closely related to services trade — people, capital and data — more convenient and secure.

The demonstration-zone mechanism

The flagship mechanism is the National Service Trade Innovation and Development Demonstration Zones. The MOFCOM issued the overall plan in April 2026, and 17 regions — Beijing among them — are now building demonstration zones as “comprehensive reform-and-opening platforms for services trade in the 15th Five-Year period”. The MOFCOM services-trade director, Kong Dejun, described three positioning goals. First, innovation highlands: zones should build on their location, resources and industrial strengths to push integrated innovation along industry and supply chains and expand services exports. Second, competitive operators: zones should widen financing channels, upgrade the public-service capacity of services-trade platforms, and cultivate leading services-export firms with international competitiveness. Third, policy-innovation sources: zones should explore an enabling institutional environment for the cross-border movement of funds, people, technology and data, steadily and orderly expand services market opening, simplify licensing approval procedures and improve risk-prevention mechanisms.

What this means on the ground

The differentiated positioning is concrete. Beijing will raise its full-chain transport-services capacity; Shanghai will open up the full international services chain for aircraft; Guangzhou will use its Greater Bay Area core-engine role to innovate in finance and foreign-related legal services; Chengdu will build a biomedicine innovation chain and digital-content export clusters. For foreign service providers, the pattern is clear: services are the frontier of liberalisation, and the demonstration zones are where new licences and new business forms get their first trial. The cross-border services-trade negative list — the mirror image of the goods negative list — will be the document that defines what is open by default and what remains restricted, and its “non-prohibited means open” logic is the most important single rule for foreign providers to internalise.

Practical guidance for foreign service providers

Foreign services companies should take four steps. (1) Map your sector against the services negative list: if your activity is not on the list, it is open by default under the filing/registration regime; if it is listed, check the specific restriction (ownership cap, licensing condition, local-presence requirement). (2) Identify the pilot ground: if your business is in a restricted or pilot area, the demonstration zones and the earlier services-opening pilots (e.g. the 119-task services-opening round) are the places where access is being tested first — engaging a zone can put you ahead of the national timeline. (3) Watch the factor-flow agenda: the commitment to make people, capital and data flow more conveniently is not a slogan — the demonstration zones are authorised to explore field-level data-export negative lists and simplified procedures, which directly affect how a services firm operates across borders. (4) Use the CIFTIS channel: the fair, held annually in Beijing, is the de facto annual checkpoint where services-opening measures and zone achievements are presented — a useful intelligence and networking event for entry planning.

Sources


服务业站上 C 位:2026 年 8 月底的市场准入开放图景

8 月 28 日的发布会

2026 年 8 月 28 日,国务院新闻办公室举行发布会,介绍中国服务贸易发展和 2026 年服贸会筹备情况。商务部官员借此平台阐明了以服务业为重点的开放议程。副部长鄢东表示,”十五五”时期,在全球产业链加速重构、数智化和绿色转型加快的背景下,商务部将深入实施服务业提质扩能行动,加快服务贸易创新发展,并——关键表述——”稳妥有序推动以服务业为重点扩大市场准入和开放领域”。他还承诺完善跨境服务贸易负面清单管理制度,破除跨境服务贸易壁垒,推动与服务贸易密切相关的人员、资金、数据等要素便利、安全地跨境流动。

示范区机制

旗舰机制是国家服务贸易创新发展示范区。商务部 2026 年 4 月印发总体方案,北京等 17 个地区正在建设示范区,定位为”十五五”时期服务贸易综合改革开放平台。商务部服贸司司长孔德军阐述了三个定位目标。其一,创新发展高地:示范区应立足区位、资源与产业优势,推进产业链供应链集成创新,扩大服务出口。其二,培育竞争优势主体:拓宽企业融资渠道,提升服务贸易平台载体公共服务能力,培育具有国际竞争力的服务出口领军企业。其三,政策创新策源地:探索优化资金、人员、技术、数据等要素跨境流动的制度环境,稳步有序扩大服务市场开放,简化有关许可审批程序,完善风险防控机制。

落地意味着什么

差异化定位已经具体化。北京提升全链条运输服务能级;上海打通飞机国际服务链条;广州发挥粤港澳大湾区核心引擎功能,创新发展金融、涉外法律等服务;成都打造生物医药创新链、数字文创出口集群。对外资服务提供商,图景清晰:服务业是开放先行领域,示范区是新牌照与新业态的试验场。跨境服务贸易负面清单——货物负面清单的镜像——将界定”默认开放”与”仍受限”的边界,其”未禁止即开放”的逻辑是外资服务商最需要内化的单一规则。

给外资服务商的实操建议

外资服务企业建议落实四步。(1)对照服务贸易负面清单定位本行业:业务不在清单上即默认开放,走备案/登记制;在清单上则核对其体的限制(持股上限、许可条件、本地存在要求)。(2)找到试验场:业务处于受限或试点领域时,示范区和此前的服务业开放试点(如 119 项服务业开放试点任务)是准入最先被测试的地方——接入一个示范区可能让你领先全国时间表。(3)盯住要素流动议程:让人员、资金、数据更便利流动不是口号——示范区获授权探索字段级数据出境负面清单与简化程序,直接影响服务企业的跨境运营方式。(4)用好服贸会渠道:每年在北京举办的服贸会实际上是服务业开放措施与示范区成果的年度检阅点——是入华规划中很有价值的信息与社交场合。

Sources

Dalian’s Services-Opening Pilot Goes Operational: Medical Access Guides and the Implementation Plan

  • In August 2026 Dalian stepped up its services-opening pilot: the municipal commerce bureau opened a 7-day public comment on the Dalian Implementation Plan for the Services Industry Expansion and Opening Comprehensive Pilot (draft), while the municipal health commission issued three compliance guides for foreign doctors opening clinics, foreign-invested non-profit medical institutions and short-term practice by overseas physicians.
    2026 年 8 月,大连加码服务业扩大开放试点:市商务局对《大连市服务业扩大开放综合试点实施方案(草案)》公开征求意见(7 天);市卫生健康委发布三项合规办事指引,覆盖外籍及港澳台医生开设诊所、中外合资合作非营利性医疗机构、境外医师短期执业。
  • Dalian is one of nine cities — together with Ningbo, Xiamen, Qingdao, Shenzhen, Hefei, Fuzhou, Xi’an and Suzhou — added to the national services-opening pilot in 2025, carrying 159 pilot tasks assigned by the Ministry of Commerce in January 2026.
    大连是 2025 年新增的 9 个服务业扩大开放综合试点城市之一(另有宁波、厦门、青岛、深圳、合肥、福州、西安、苏州),承接商务部 2026 年 1 月赋予的 159 项试点任务。
  • The medical guides convert national pilot tasks into standardised filing procedures: clear legal bases, applicant conditions, document checklists and process steps for overseas medical professionals and institutions to practise or establish entities in Dalian.
    医疗三项指引把国家试点任务转化为标准化审批办事规范:明确境外医疗人才、机构来连执业办医的办理依据、申请条件、申报材料与办理流程。
  • The pilot tasks cover telecom services, healthcare, business, culture and tourism and finance, with each city encouraged to design distinctive tasks based on local strengths — Dalian’s health-sector focus reflects its industrial base.
    试点任务覆盖电信服务、医疗康养、商贸文旅、金融等重点领域,鼓励各城市结合自身优势设计个性化任务——大连聚焦医疗审批改革与其产业基础契合。
  • For foreign healthcare providers, the practical entry point is clear: use the three Dalian guides to prepare clinic-licensing or short-term-practice filings, and watch the city’s implementation plan for wider services-opening commitments.
    对外资医疗机构与境外医师,实操入口明确:按大连三项指引准备诊所设置或短期执业申报,并关注该市实施方案中的更广开放承诺。

Dalian’s Services-Opening Pilot Goes Operational: Medical Access Guides and the Implementation Plan | 大连服务业扩大开放试点落地:医疗开放指引与实施方案

From national pilot to city-level rules

Dalian was one of nine cities added to the national services industry expansion and opening comprehensive pilot in 2025 — together with Ningbo, Xiamen, Qingdao, Shenzhen, Hefei, Fuzhou, Xi’an and Suzhou — bringing the pilot network to 20 cities. In January 2026 the Ministry of Commerce issued the pilot tasks for these nine cities: 159 tasks spanning telecom services, medical and healthcare, business, culture and tourism, and finance, with a “common plus distinctive” structure that lets each city combine national commitments with locally tailored measures. In August 2026 Dalian translated this national framework into local, operational rules. On 20 August the municipal commerce bureau published the Dalian Implementation Plan for the Services Industry Expansion and Opening Comprehensive Pilot (draft) for a seven-day public comment period. Days earlier, the municipal health commission released three compliance guides covering the healthcare tasks.

The three medical compliance guides

The three guides issued by the Dalian health commission are: (1) the Compliance Guide for Foreign and Hong Kong, Macao and Taiwan Doctors Opening Clinics in Dalian; (2) the Compliance Guide for Applying to Establish Sino-foreign Jointly Invested or Co-operated Non-Profit Medical Institutions in Dalian; and (3) the Compliance Guide for Overseas Physicians Conducting Short-Term Practice in Accordance with Regulations in Dalian. Each guide standardises the approval chain end to end: the legal basis, applicant conditions, required documents and the filing process, converting national pilot tasks into the day-to-day norms that local regulators will apply. The three areas covered — foreign doctors’ clinics, short-term practice by overseas physicians and non-profit joint medical institutions — correspond exactly to the tasks the national pilot assigns to the healthcare sector.

What the draft implementation plan signals

The draft implementation plan, open for comment until 26 August, sets out how Dalian will implement the 159 tasks more broadly. It is grounded in the MOFCOM notice on the nine-city pilot tasks (Shang Zi Han [2026] No. 5) and, once finalised, will be the reference document for foreign investors assessing Dalian’s services sector. Combined with the medical guides, it signals that Dalian intends to be a practical testbed: national policy is being converted into city-level processes that businesses can follow, rather than left as abstract commitments.

Why it matters for foreign healthcare and services investors

For foreign healthcare providers, the package matters for three reasons. First, entry clarity: the three guides specify exactly what an overseas physician needs to open a clinic or practise short-term in Dalian — reducing the uncertainty that historically surrounded medical licensing for foreign professionals. Second, breadth: the implementation plan, once final, will clarify Dalian’s approach to telecom, business, culture and tourism and finance tasks, helping investors see the full opening landscape rather than a single sector. Third, precedent value: Dalian is among the first of the nine 2025-vintage pilot cities to convert its tasks into published compliance guides, so the format is likely to be imitated by other cities — making the Dalian documents useful templates for understanding how services opening is being operationalised across China.

Practical steps

Foreign investors and medical professionals should: (1) review the three health-commission guides against their specific plans — clinic establishment, short-term practice or a non-profit joint institution — and assemble the document package each guide lists; (2) engage the Dalian health commission early on applicant qualifications, since foreign-doctor clinic rules require careful checking of professional credentials and prior practice records; (3) track the finalised version of the implementation plan through the Dalian commerce bureau for wider services commitments; and (4) for investors comparing Chinese cities, treat Dalian’s published guides as one example of how the nine-city pilot tasks are being implemented, and benchmark against the progress of peer cities such as Fuzhou, Shenzhen and Xi’an.

The wider context: services opening as a national agenda

Dalian’s package sits inside a broader national push that foreign investors should read as a trend, not a one-off. The “15th Five-Year Plan” outline treats services as the main front of opening: expanding market access in telecom, internet, education, culture and healthcare, and steadily running the value-added telecom, biotech and wholly foreign-owned hospital pilots. Two negative lists are the operational instruments — the foreign-investment negative list and the cross-border services trade negative list — and pilot FTZs and services-opening pilot cities are the testbeds. For a foreign services provider, the practical implication is that city-level documents like Dalian’s implementation plan and compliance guides are where national commitments become enforceable processes; monitoring them is the difference between reading about opening and actually entering a market. The same mechanics — a national task, a local implementation plan, sector-specific compliance guides — are being replicated across the nine new pilot cities, so a company that understands Dalian’s format can apply the same analytical lens to Fuzhou, Shenzhen, Qingdao and the rest.

Sources


大连服务业扩大开放试点落地:医疗开放指引与实施方案

从国家试点到市级规则

大连是 2025 年新增的 9 个服务业扩大开放综合试点城市之一(另有宁波、厦门、青岛、深圳、合肥、福州、西安、苏州),试点网络由此扩围至 20 城。2026 年 1 月,商务部印发 9 城市服务业扩大开放综合试点任务:159 项任务覆盖电信服务、医疗康养、商贸文旅、金融等领域,采用”共性+个性”结构,鼓励各城市把国家承诺与本地特色结合。2026 年 8 月,大连将国家框架转化为本地操作性规则。8 月 20 日,市商务局发布《大连市服务业扩大开放综合试点实施方案(草案)》并公开征求意见(7 天);此前数日,市卫生健康委发布覆盖医疗领域试点任务的三项合规办事指引。

三项医疗合规指引

大连市卫健委发布的三项指引为:(1)《大连市外籍及港澳台医生开设诊所合规办事指引》;(2)《大连市申办中外合资、合作非营利性医疗机构合规办事指引》;(3)《大连市境外医师按规定从事短期执业活动合规办事指引》。每项指引对审批链条做全流程标准化:办理依据、申请条件、申报材料、办理流程,把国家试点任务转化为地方监管日常适用的规范。三个覆盖领域——外籍医生诊所、境外医师短期执业、中外合资非营利性医疗机构——与全国试点赋予医疗行业的任务一一对应。

实施方案草案的信号

实施方案草案(征求意见截止 8 月 26 日)明确大连将如何更广地落实 159 项任务。文件依据商务部 9 城市试点任务通知(商资函〔2026〕5 号)制定,定稿后将成为外资投资者评估大连服务业的参考文件。与医疗指引结合,方案传递的信号是:大连要做实操试验田——国家政策被转化为企业可遵循的城市级流程,而非停留在抽象承诺。

对外资医疗与服务投资者的意义

对外资医疗机构,这一揽子安排有三重意义。第一,准入清晰:三项指引精确说明境外医师在大连开设诊所或短期执业需要什么,降低了外籍医疗执业许可长期以来的不确定性。第二,广度:实施方案定稿后将明确大连对电信、商贸、文旅、金融任务的态度,投资者可见全貌而非单一行业。第三,先例价值:大连是 2025 年批次 9 城市中率先把试点任务转化为公开合规指引的城市之一,格式很可能被其他城市效仿——大连文件因此成为理解全国服务业开放如何落地化的有用模板。

操作建议

外资投资者与境外医疗专业人士应:(1)对照三项指引核对自己的具体计划——开设诊所、短期执业或非营利性合资机构——并按指引清单准备材料包;(2)尽早与大连市卫健委沟通申请人资质,外籍医生诊所规则对执业资格与既往执业记录核对要求细致;(3)通过市商务局跟踪实施方案定稿版,获取更广服务承诺;(4)比较不同中国城市时,把大连的公开指引视为 9 城市试点任务落地的一个样本,并与福州、深圳、西安等同批城市进展对标。

更大背景:服务业开放作为国家议程

大连的一揽子安排处在一个更广的国家推进之中,外国投资者应视之为趋势而非一次性事件。”十五五”规划纲要视服务业为开放主战场:推动电信、互联网、教育、文化、医疗等领域有序扩大开放,稳妥实施增值电信、生物技术、外商独资医院等开放试点。两张负面清单是操作工具——外商投资准入负面清单与跨境服务贸易负面清单——自贸试验区与服务业扩大开放试点城市是试验田。对外资服务商,实际含义是:像大连实施方案与合规指引这样的城市级文件,正是国家承诺转化为可执行流程之处;跟踪它们是”读到开放”与”真正进入市场”的区别。同一机制——国家任务、地方实施方案、分行业合规指引——正在 9 个新增试点城市复制,理解了大连格式的企业可以把同样的分析框架套用于福州、深圳、青岛等城市。

Sources